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ABSTRACT 
Several classes of membrane proteins refold from their original soluble conformations in 
response to acidification and insert into lipid bilayers.  Despite the recent advances in 
unraveling the molecular mechanisms of pH-triggered insertion of membrane proteins, 
many aspects of this process remain unknown.  In this study we used two proteins that 
share structural similarities as model systems: the diphtheria toxin translocation domain (T 
domain) and the anti-apoptotic regulator Bcl-xL.  We addressed the following specific 
questions:  (1) Do structurally similar T domain and Bcl-xL share common mechanisms of 
membrane insertion?  (2) What is the role of titratable histidine residues on the late stages 
of transmembrane insertion of the T domain?  (3) How do the physicochemical properties 
of the lipid bilayer modulate the pH-triggered membrane insertion of Bcl-xL?  First, we 
characterized the main features of the pH-triggered membrane insertion pathway of Bcl-xL 
using circular dichroism (CD) and a battery of fluorescence-based methods and compared 
them to those previously determined for the T domain.  We demonstrate that both proteins 
follow distinct membrane insertion pathways despite of the structural similarities of the 
initial solution and putative final transmembrane folds.  Second, we used site-directed 
mutagenesis and functional and spectroscopic assays to characterize the membrane 
interactions of the C-terminal histidines of the T domain.  We determine that H322 is 
critical for proper refolding of the N-terminal helices within the membrane, which is 
critical for the formation of the Open-Channel State of the T domain within the lipid 
bilayer.  Finally, we determined the role of various lipids on the membrane interactions of 
Bcl-xL using several fluorescence-based techniques.  We demonstrate that the initial 
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membrane association of Bcl-xL is modulated by the membrane surface potential, while the 
transmembrane insertion is regulated by additional properties, e.g. mechanical stress.  We 
conclude that the pH-triggered membrane insertion of proteins can be modulated at 
multiple levels, including protonation of specific titratable residues and changes in the 
membrane lipid composition.  These differences in the mechanisms of regulation are 
relevant to the physiological function of the corresponding membrane proteins (e.g., T 
domain and Bcl-xL). 
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CHAPTER 1 INTRODUCTION 
Membrane proteins (MPs) are critical for proper cellular function.  They control the selective 
crossing of molecules through biological membranes and energy production, serve as support for 
the cytoskeleton, regulate apoptosis, and are involved in cell signaling, among other tasks.  It is 
predicted that MPs constitute about 25-35% of the human proteome [1, 2], and they are the target 
of almost 60% of the pharmaceutical drugs [3, 4].  However, despite their biological and 
pharmaceutical significance, much less is known regarding the structure and assembly of MPs in 
their native environment in comparison to their soluble counterparts (only 535 unique MPs of 
known high resolution structure up to April of 2015, http://blanco.biomol.uci.edu/mpstruc/).  The 
technical difficulties and the intrinsic complexity of the lipid bilayer hinder the understanding of 
fundamental principles behind membrane protein folding [5-7].  Because some membrane 
proteins are initially synthesized in the relatively isotropic environment of the cytosol or 
extracellular fluid (e.g. bacterial toxins), they serve as model proteins to understand membrane 
protein folding.  In this chapter, we first discuss the structure and physical properties of the 
membrane and the physical principles involved in membrane protein folding.  Then, we 
introduce the pH-triggered membrane insertion and refolding of proteins as a model system to 
study membrane protein folding, with emphasis in the diphtheria toxin translocation domain and 
the apoptotic regulator Bcl-xL.  
BIOLOGICAL MEMBRANES 
Membrane proteins reside in a lipid environment and the structure and dynamics of membrane 
proteins depend on the molecular structure and physicochemical properties of the lipid milieu.  
Therefore, we will first discuss the physical and chemical organization of biological membranes.  
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Chemical composition 
Biological membranes function as selective permeability barriers that separate different 
compartments in the cell.  They are composed of amphiphilic molecules (i.e. they are both 
hydrophobic and hydrophilic), called membrane lipids, arranged in a continuous double layer 
structure with the hydrophobic regions facing each other and the hydrophilic heads facing the 
aqueous phase [8].  Biological membranes are formed by several types of lipids, including 
glycerophospholipids, sphingolipids and sterols [9, 10].  Glycerophospholipids (usually referred 
simply as phospholipids) are formed by two acyl chains attached to a glycerol moiety, with a 
phosphate group linking a hydrophilic headgroup to the third carbon of the glycerol (e.g 
phosphatidylcholine, Fig. 1.1B).  In sphingolipids, however, the glycerol group and one of the 
acyl chains are substituted by a sphingosine moiety.  Some sphingolipids also contain a 
phosphate group (e.g. sphingomyelin), while others have complex oligosaccharides attached 
(gangliosides).  Finally, sterols are moieties with multiple aromatic rings and a single hydrophilic 
functional group (e.g. cholesterol). 
The variety in the lipid composition of membranes goes beyond the mere replacement of 
glycerol with sphingosine.  Several natural functional groups are known to be attached to the 
phosphate moiety, including glycerol, choline, serine and inositol, among others.  The aliphatic 
chains of these lipids have lengths ranging from 4 to >30 carbons, and different levels of 
saturation.  Unsaturated acyl chains can be mono- or polyunsaturated fatty acids and have a cis 
or trans configurations at the double bond.  Thus, only counting the length, saturation and 
configuration of acyl chains, and the functional group attached to the phosphate, cells synthesize 
thousands of different lipids with different chemical and physical properties.  A comprehensive 
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review on the synthesis and location of these lipids can be found in reference [8], while 
structures and physicochemical properties of them can be found in the LIPID MAPS database 
(http://www.lipidmaps.org/data/structure/) [10].  In this dissertation, we focus on the most 
common glycerophospholipids with a single configuration at the acyl chains (See Table 4.1 for 
structures and properties).  For simplicity, we referred as them simply as phospholipids or lipids. 
Structure and physical properties of the lipid bilayer 
Given the complex composition of the lipid bilayer, it is challenging to visualize the structure 
of the membrane at a high resolution level.  Fig. 1.1A shows a snapshot of a lipid bilayer 
composed of phosphatidylcholine created by computational molecular modelling [11].  Although 
this membrane is made of only one type of lipid, it is clear that there is enormous thermal 
disorder that complicates even more the creation of a resolution model of the membrane.  In the 
picture, however, it is possible to visualize the general structure of the membrane, with lipids 
arranged in a double layer, the hydrophobic tails (sticks) facing each other, and the functional 
groups of the lipid headgroups (balls) in contact with the water molecules (light blue).   
A more accurate representation of the membrane is determined by time averaging the position 
of functional groups along the normal axis z of the membrane using X-ray and neutron scattering 
of oriented multilamellar membranes [12] (Fig 1.1B).  The structure of a DOPC membrane is 
presented in Fig. 1.1C, where the spatial distribution of each functional group along the bilayer 
normal axis z is shown as a histogram.  Three features of this membrane are immediately 
evident.  First, the hydrocarbon core is flanked by two interfacial regions whose combined width 
(~15Å each) equals that of hydrocarbon core (~30Å).  Second, the membrane interface is 
chemically complex and contains the functional groups of the lipid headgroups and water of 
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hydration.  The hydrocarbon core, on the other hand, contains the lipid acyl chains.  Third, there 
is a gradient of polarity that decreases from the aqueous phase to the hydrocarbon core (Fig. 
1.1D), passing through the interfacial region.  The width of the distributions is consistent with 
the thermal disorder.  This type of arrangement holds true for membranes composed of other 
lipid systems [13-16]; however, combination of different lipids are expected to create a more 
complex picture, possibly with lipid domains of different structures and physicochemical 
properties [6, 17]. 
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FIGURE 1.1 Structure of lipid bilayer.  A) DOPC lipid bilayer modeled through 
computational methods illustrating the substantial thermal disorder [11].  B) Schematic 
representation of the structure of a phosphatidylcholine molecule.  While acyl chains are 
hydrophobic, the headgroup is hydrophilic.  The estimation of the time averaged probability of 
functional groups across the bilayer normal axis z determines the structure of the bilayer.  C)  
Structure of a DOPC bilayer determined by X-ray and neutron diffraction as illustrated in panel 
B [12].  Notice the presence of a 30Å wide hydrocarbon core flanked by two interfacial regions 
of 15Å each (width accommodates α-helix).  Interface is chemically complex and includes 
functional groups of lipid headgroups and water of hydration.  D) Charge density along the 
bilayer normal axis shows a gradual decrease of charges from the interface towards the 
hydrocarbon core.  Panels B-D are taken from website of Dr. Stephen White Lab at University of 
California, Irvine (http://blanco.biomol.uci.edu/Bilayer_Struc.html). 
 
MEMBRANE PROTEINS 
Structural and thermodynamic features of membrane proteins 
Membrane proteins (MPs) are embedded in the lipid bilayer, either via a transmembrane or 
interfacially moiety.  Regardless of the mode of attachment, they share some features with 
soluble proteins, while others are unique to membrane proteins.  A comparison with soluble 
proteins reveals that membrane proteins are not inside-out structures [18].  In fact, one of the first 
solved structures of the photoreactive center bacteriorhodopsin revealed that the majority of 
amino acids in the interior of the protein were non-polar [19].  The exceptions are the pore-
forming proteins (e.g. porins, bacterial toxins), whose interiors are water-filled [20, 21].  Other 
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common elements between the interior of soluble proteins and membrane proteins are the 
presence of salt bridges and formation of hydrogen bonds.  Thus, packing and general principles 
of folding of membrane proteins are not as different as those of soluble proteins [18, 22].  
However, some features are more specific to MPs.  For example, the exterior of membrane 
proteins is more hydrophobic than that of soluble proteins [23].  Finally, α-helices are usually 
longer in MPs because they must span the entire hydrophobic core of the lipid bilayer (~30A) to 
be thermodynamically stable (see below) [18]. 
Membrane proteins adopt a limited number of folds within the membrane [18, 24]: 
transmembrane α-helical bundles and β-barrels (Fig. 1.2A-B).  Because membrane proteins exist 
in thermodynamic equilibrium with their environment, they fold in agreement with the laws of 
thermodynamics [18, 25, 26].  Hydrogen bond formation (H-bond) within the protein backbone, 
resulting in secondary structure formation, reduces the large energetic cost of bringing the 
backbone into the hydrophobic core of the bilayer [18].  According computational calculations, 
this reduction is about 4.2 kcal/mol per residue [27, 28], which in a 20 residue-long peptide 
(average length of a transmembrane helix) adds to more than 80 kcal/mol.  Thus, the most stable 
motifs within the membrane are those where the protein backbone is fully H-bonded: α-helices 
and β-barrels.  There is a third type of topology generally found in membrane proteins: 
interfacial α-helices (Fig 1.2C).  In this case, H-bond formation stabilizes the protein backbone in 
about 0.37 kcal/mol per residue [29].  This number does not appear as large as that achieved by 
H-bond formation in the hydrocarbon core, but it is large enough to drive the formation of α-
helices in the membrane interface (a 15-residue helix is about 5.5 kcal/mol more stable than the 
unfolded peptide). 
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FIGURE 1.2 Examples of the thermodynamically permitted folds of membrane proteins.  
A) Transmembrane α-helical bundles, B) β-barrels, C) and interfacial α-helices.  Structures 
correspond to the glucose transporter GLUT1 (4PYP) [30], voltage-dependent anion channel 
VDAC1 (2JK4) [31], and the bee venom melittin (2MLT) [32].  H-bond formation at the protein 
backbone drives the thermodynamic equilibrium of these structures within the lipid bilayer (see 
text for details).  For simplicity, the membrane is shown as two parallel lines with the shadowed 
areas representing the interfacial region. 
Membrane insertion of proteins 
According their mode of membrane insertion, MPs can be classified into two groups: those 
that require the help of another protein, i.e. translocons; and those that insert spontaneously 
without the help of other proteins.  Because this dissertation addresses the second type of 
membrane protein insertion, the protein-assisted membrane protein folding will be merely 
mentioned.  The protein-assisted membrane insertion requires the action of complex machineries 
to assist the integration of transmembrane segments into the bilayer.  The machinery is different 
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depending on the organism and the MP fold.  For example, the Sec complex assists on the 
membrane insertion of α-helical proteins [33, 34], where the ribosome is attached to the 
translocon to ensure the co-translational insertion of MPs (Fig. 1.3A).  The Sec61 complex is the 
eukaryotic variant and is found in the membrane of the endoplasmic reticulum, while the 
SecYEG is the bacterial homolog and is found in the bacterial inner membrane.  Membrane 
proteins with β-barrel topology use a different type of assembly machineries [35, 36], where 
SAM (sorting and assembly machinery) and TOC (translocon of the outer membrane of 
chloroplasts) complexes chaperone the insertion and folding of β-barrel proteins in mitochondria 
and chloroplast, respectively.  BAM (β-barrel assembly machinery) is the bacterial homolog.  
Although the molecular details of the membrane action of these assembly machineries are only 
partially understood [37-41], it is clear that their action is critical for the proper folding of MPs. 
Several classes of membrane proteins adopt their transmembrane topology after being 
synthesized as water-soluble structures.  Examples include bacterial toxins [42-44] and colicins 
[45], which are secreted to the extracellular space; and certain annexins [46] and members of the 
Bcl-2 proteins [47], which are synthesized as cytosolic proteins.  The unique characteristic of 
these proteins is their ability to move from the polar environment of the aqueous medium to the 
non-polar milieu of the lipid bilayer without the help of translocons or assembly machineries 
(Fig. 1.3B).  This process occurs in response to a given cellular signal (e.g. change in pH, 
proteolytic cleavage) and involves a massive refolding of the solution structure of the protein.  
The exact molecular mechanism of this refolding/insertion process is not fully understood, and 
some open questions will be addressed during this dissertation.  In the following sections, we 
will introduce two proteins that insert into the membrane under acidic conditions, the diphtheria 
9 
 
toxin T domain and the apoptotic repressor Bcl-xL, and three open questions that will be 
addressed in the following chapters. 
 
FIGURE 1.3 Mechanisms of membrane protein insertion.  A) Schematic representation of the 
insertion of a membrane protein assisted by Sec61 [37].  In the example, the glucose transporter 
GLUT1 [30] is inserted into the lipid bilayer assisted by the Sec61 translocon [48].  The 
mechanism involves the passage of the nascent chain from the ribosome through a channel in the 
Sec61 protein before entering the lipid bilayer.  B) Schematic representation on the spontaneous 
membrane insertion of proteins.  In the example, the diphtheria toxin translocation domain 
inserts into the membrane in response to acidification without the help of other proteins [43].  
For diphtheria toxin T domain, models correspond to the crystal structure in solution at neutral 
pH [49] and a membrane-inserted model based on spectroscopic and functional assays [50-53]. 
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DIPHTHERIA TOXIN TRANSLOCATION DOMAIN 
The diphtheria toxin is a protein synthesized and released by the bacterium Corynebacterium 
diphtheriae.  The toxin is composed of three domains (Fig. 1.4A) [49]: the catalytic domain (C-
domain), the translocation domain (T domain), and the receptor-binding domain (R domain).  
The toxin enters the target cell via the endosomal pathway of internalization [42], which is 
initiated by the attachment of the R domain to its receptor in the target membrane (Fig. 1.4B).  
Upon endosomal internalization and acidification (endosomes can reach pH values as low as 5 
[54-56]), the T domain undergoes a series of pH-triggered conformational changes that lead to its 
membrane binding and insertion [43].  As a result of T domain’s membrane insertion, the N-
terminus and the attached C domain are translocated across the endosomal membrane.  The C 
domain, now in the cytosol, inhibits protein synthesis by ADP-ribosylating the translation factor 
EF-2.  Thus, the T domain plays a key role in the entry of the C domain, which ultimately causes 
cell death. 
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FIGURE 1.4 Entry of the diphtheria toxin into cells. A) Crystal structure of the diphtheria 
toxin [49] showing its three domains as ribbons of different colors.  B) Schematic representation 
of the endosomal entry of the diphtheria toxin into the cell [42].  The red box highlights the step 
under discussion in this chapter. 
The crystal structure of the T domain in solution at neutral pH shows 9 α-helices [49], named 
TH1 to TH9, arranged in a globular fold (Fig. 1.5).  Two of these helices, TH8 and TH9 (purple 
helices), form the hydrophobic core of the protein in solution.  The remaining helices are 
amphipathic helices that surround the core of the protein and keep it soluble in an aqueous 
environment.  There is no high resolution structure available for the membrane-inserted state.  
However, multiple evidence indicates that helices TH8-TH9 insert as a transmembrane hairpin, 
with the loop connecting both helices on the trans side of the bilayer, while the rest of the 
structure adopts multiple conformations [51, 53, 57-61].  Since the N-terminus of the T domain 
is translocated across the membrane, it is argued that TH5 also takes a transmembrane topology 
[51, 59, 61, 62]. 
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FIGURE 1.5 Structural features of the diphtheria toxin T domain.  Top) Crystal structure of 
the T domain in solution at neutral pH [49].  Bottom) Structural model of the T domain in the 
membrane inserted state based on spectroscopic and functional assays [51, 53, 57-60] . 
The refolding and membrane insertion pathway of the T domain occurs in multiple steps [43], 
where the kinetic and thermodynamic features have been described [53, 63].  The kinetic 
pathway (Fig. 1.6A) starts with a conformational change in solution in response to acidification, 
where the membrane-incompetent W state is converted into the membrane-competent W
+ 
state.  
The process continues with the partitioning of the W
+
 state to the membrane interface to form the 
interfacial I state.  Finally the T domain adopts a transmembrane T state after a series of 
conformational changes within the membrane (this state is also known as open-channel state or 
OCS).  T domain can be kinetically trapped in the I state by modulating the pH and the lipid 
composition.  The folding landscape of the T domain is shown in Fig. 1.6B, where the bulk of 
free energy of stabilization of the membrane inserted state comes from the membrane binding 
event (W
+
 to I state).  Based on structural similarities, it has been hypothesized that other 
proteins (e.g. members of the Bcl-2 family of proteins) follow a similar membrane insertion 
pathway [64-66].  In Chapter 2, we test this hypothesis by comparing the membrane insertion 
pathway of Bcl-xL and that the T domain (more details in section of Bcl-2 family of proteins). 
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FIGURE 1.6 Kinetics and thermodynamics of the pH-triggered membrane insertion of the 
T domain.  A) Kinetic pathway of membrane insertion of the T domain [53].  Intermediates 
states are formed in solution and in the membrane (See text).  B) Free energy landscape for the 
folding of T domain into the membrane [63].  Bulk of free energy stabilizing the final T state 
comes from the binding step.  The arrow indicates modulation of the pathway by anionic lipids, 
which lowers the kinetic barrier of transmembrane insertion. 
It is suggested that the conformational changes of the T domain are driven by the protonation 
of histidine residues [43, 67].  There are six histidine residues in the T domain, which in the 
structure of the T domain are arranged into two clusters (Fig. 1.7): the N-terminal cluster of 
histidines and the C-terminal cluster of histidines.  The N-terminal histidines have been shown to 
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be involved in the solution refolding of the T domain (W to W
+
 state in Fig. 1.6).  Mutagenesis 
of these histidines followed by spectroscopic and functional characterization of the mutants 
revealed that protonation of H257 triggers the initial conformational changes [52].  Extended 
molecular dynamic simulations suggested that electrostatic repulsion between H257 and H223 
upon protonation initiates the initial conformational change [50], with H223 acting as a safety 
latch to prevent the refolding of the T domain at neutral pH.   
 
FIGURE 1.7 Location of histidines within the structure of the T domain.  Histidines are 
arranged into the N-terminal (light blue) and the C-terminal cluster of histidines (green).  While 
it has been demonstrated that the N-terminal histidines trigger the refolding of the T domain in 
solution, it is hypothesized that the C-terminal histidines are involved in the folding of the T 
domain within the membrane. 
The role of the C-terminal histidines is less clear, but their location on top of the membrane 
insertion unit TH8-TH9 (purple helices) suggest their involvement in the folding of the protein in 
the membrane.  Indeed, a recent study found that the triple mutation of the C-terminal histidines 
leads to a non-functional T domain in the membrane [68].  The fact that the T domain was 
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unable to form the open-channel state initially suggested its inability to insert into the membrane.  
However, the membrane insertion of helices TH8-TH9 and the translocation of the N-terminus 
were unaffected by these mutations.  Thus, it is unclear why the T domain does not reach its final 
folding state while still having an apparently normal interaction with the membrane.  Likewise, it 
is not clear if the three C-terminal histidines are involved in the final folding of the T domain 
into the OCS, or any of the histidines are more important.  We hypothesize that the C-terminal 
histidines are involved in the folding of the N-terminal helices despite being located on top of the 
helical hairpin, and that histidines connecting to the N-terminal helices will be especially 
important.  In chapter 3 this hypothesis will be tested and individual mutants of the C-terminal 
cluster of T domain will be characterized functionally and spectroscopically. 
BCL-2 FAMILY OF PROTEINS AND APOPTOSIS 
Apoptotic pathways and MOMP 
Apoptosis is a cell death program used by multicellular organisms to eliminate unwanted cells 
[69].  Apoptosis is of critical importance, as malfunction is often associated with 
neurodegenerative diseases and cancer [70, 71].  There are two known pathways of apoptosis: 
the extrinsic and the intrinsic pathway (Fig. 1.8) [47, 72].  The extrinsic route responds to certain 
external signals (e.g. tumor necrosis factor) that trigger a cascade of events in the cell upon 
binding of a signaling ligand to its receptor.  The intrinsic route takes action when internal 
cellular damage is irreversible (e.g. extensive viral damage).  A common hallmark of both 
pathways is the activation of a cascade of proteases called caspases (cysteine-aspartic proteases), 
whose function is to cleave cellular proteins, leading to cell death.  Importantly, the activation of 
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these caspases depends on a prior event known as mitochondrial outer membrane 
permeabilization (MOMP) [71-73]. 
The mitochondrial outer membrane permeabilization causes the release of the mitochondrial 
content into the cytosol (Fig. 1.8) [73].  This irreversibly redistribution of mitochondrial proteins 
initiates the execution of apoptosis through caspase activation.  For example, cytochrome C 
forms the apoptosome upon binding to a protein complex called Apaf-1.  The apoptosome 
directly activates caspase-3, which digests cellular proteins.  Another group of mitochondrial 
proteins known as SMACs (small mitochondrial-derived activator of caspases) indirectly activate 
apoptosis by sequestering and preventing the action of inhibitors of caspases.  Because MOMP is 
irreversible, and it causes a dual activation of caspases, it is considered to be the point of no 
return towards cell death.  MOMP is controlled by the action of a group of proteins known as the 
Bcl-2 family of proteins. 
Bcl-2 proteins 
The mitochondrial outer membrane permeabilization is tightly controlled by the action of the 
Bcl-2 family of proteins.  The Bcl-2 family of proteins is subdivided into three groups based on 
their apoptotic action and sequence homology [74].  The proapoptotic members (e.g. Bax, Bak) 
contain three homology domains, BH1-3 (Bcl-2 homology domain), and promote MOMP.  The 
antiapoptotic or prosurvival members (e.g. Bcl-xL, Bcl-2) share four homology domains, BH1-4, 
and prevent MOMP.  The BH3-only members (e.g. Bid, Bim) contain only the BH3 domain and 
have been reported to sensitize apoptotic signals, activate proapoptotic members, and inhibit 
antiapoptotic members.  The molecular mechanism of action of the Bcl-2 family of proteins 
remains unclear despite active research [75, 76].  Importantly, some members of the Bcl-2 family 
17 
 
of proteins reside in both the cytosol and the mitochondrial outer membrane, and its dynamic 
exchange is suggested to be part of their molecular mechanism [77-81].  
 
FIGURE 1.8 Apoptotic pathways, MOMP and Bcl-2 family of proteins.  There are two 
pathways leading to apoptosis depending on the origin of the cell death signal: intrinsic and 
extrinsic routes.  Bcl-2 proteins control the release of cytochrome C and other mitochondrial 
proteins into the cytosol, leading to the activation of a cascade of caspases. Caspases then digest 
the cellular proteins and activate DNases, causing the demolition of the cell.  (Figure taken from 
reference [47]). 
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The most accepted model for the mechanism of action of the Bcl-2 family of proteins is the 
embedded together model (Fig. 1.9) [82].  According to this model, there are multiple 
interactions between pro- and anti-apoptotic members of the Bcl-2 family of proteins.  In the 
absence of anti-apoptotic members, pro-apoptotic members are recruited from the cytosol into 
the lipid bilayer, where they oligomerize and form a pore that permeabilizes the mitochondrial 
outer membrane.  In the presence of anti-apoptotic members, this oligomerization is inhibited.  
For instance, in the scheme shown in Fig. 1.9, pro-apoptotic Bid (blue) is activated by proteolytic 
cleavage, promoting its own partitioning and that of the pro-apoptotic Bax to the mitochondrial 
membrane.  Bax oligomerizes, which causes pore formation and release of apoptotic factors into 
the cytosol [83] and cell death.  It is not clear how Bcl-xL (purple) prevents cell death, but it is 
suggested that Bcl-xL either competes with Bax for binding sites in tBid or sequesters Bax 
molecules to prevent its oligomerization, or both.  In either case, Bcl-xL plays a critical role on 
apoptotic regulation since it is the last line of defense to prevent cell death.  From this point, we 
will focus on the membrane action of Bcl-xL. 
 
19 
 
FIGURE 1.9 The Embedded Together Model of apoptosis regulation [82].  Multiple 
interactions between Bcl-2 family members occur in solution and in the mitochondrial membrane 
to either promote or prevent the formation of a pore that permeabilizes the mitochondrial outer 
membrane.  For example, cleavage of Bid (blue, BH3-only) upon a death signal forms tBid, 
which can induce membrane partitioning of both Bcl-xL (purple, anti-apoptotic) and Bax (green, 
pro-apoptotic).  Bax oligomerizes in the membrane and forms the apoptotic pore.  Bcl-xL 
sequesters tBid and Bax to prevent their pro-apoptotic action.  Apoptosis occurs when Bcl-xL is 
unable to prevent the apoptotic function of tBid and/or Bax.  The membrane not only acts as 
platform, but also regulates the dissociation constants of these protein-protein interactions [84]. 
Bcl-xL 
Bcl-xL was the first member of the Bcl-2 family of proteins with known high resolution 
structure [66].  The NMR (Fig 1.10A) and X-ray structure of Bcl-xL shows 7 α-helices (α1 to 
α7) arranged in a globular fold.  Helices α5 and α6 form the hydrophobic core of the protein, 
which is surrounded by the remaining helices.  Bcl-xL has an additional helix, TM helix, which 
was truncated to crystallize the protein because it reduces the solubility of the protein [66].  
Because of its hydrophobicity, it was suggested that the TM helix anchors Bcl-xL to the 
membrane (Fig. 1.10B, TM helix is modeled in blue).  Experimental evidence indicates that the 
isolated TM helix indeed adopts a transmembrane topology [85].  A recent NMR study reports 
that the TM helix anchors Bcl-xL to lipid nanodiscs [86], supporting the role of this helix as the 
initial attachment of Bcl-xL to the mitochondrial membrane.  Thus, Bcl-xL is composed of two 
domains: the soluble or N-terminal domain, and the TM helix.  Although the TM helix has been 
suggested to be important for the interactions with Bax [87], it is not clear if it is necessary for 
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membrane partitioning of the soluble domain.  In fact, Bcl-xL can interact with the membrane at 
low pH in the absence of the TM helix [65, 84, 88-90].  For the purposes of this dissertation, 
where we study the membrane insertion of the soluble domain, the TM helix is truncated. 
 
FIGURE 1.10 High resolution structure of Bcl-xL (PDB 1LXL) [66].  A) NMR structure of 
Bcl-xL lacking the TM helix.  Helices α5 and α6 (purple) form the hydrophobic core of the 
protein.  B) Putative model of Bcl-xL attached to the membrane through the TM helix as 
suggested in references [85, 86].  In this dissertation we study the membrane insertion of the 
soluble domain, so the TM helix is truncated. 
Several mechanisms have been proposed for the inhibitory role of Bcl-xL.  For example, Bcl-
xL sequesters Bax in the membrane, which prevents the oligomerization of Bax [83].  Similarly, 
Bcl-xL sequesters tBid in the membrane, hence reducing the chances of tBid recruiting and 
activating Bax [76].  Finally, Bcl-xL exists in a dynamic equilibrium between its cytosolic and 
its membrane-bound form, where it can pull Bax out of the membrane during its dissociation [80, 
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81].  Whatever the case, Bcl-xL must partition from the cytosol into the mitochondrial membrane 
to execute its pro-survival action.  
COMPARISON OF BCL-XL TO THE DIPHTHERIA TOXIN TRANSLOCATION DOMAIN 
The initial characterization of Bcl-xL revealed that its high resolution structure resembled that 
of the diphtheria toxin T domain.  Fig. 1.11 shows the crystal structures of both proteins as 
initially reported [66].  Both proteins share a similar globular fold in solution under neutral 
conditions, with helices arranged in a similar fashion: two central hydrophobic helices (colored 
in red in Fig. 1.11) surrounded by amphipathic helices.  Although the structural similarities end 
there, this comparison was crucial for apoptosis research.  When the structure of Bcl-xL was 
initially published, the role of the Bcl-2 proteins (only a few Bcl-2 proteins were known to exist) 
in apoptosis regulation was unknown.  On the other hand, the function of the diphtheria toxin T 
domain was well known [91, 92].  The similarities between the structure of Bcl-xL and that of 
the T domain led to test the Bcl-2 proteins as pore-forming proteins [65, 93-95], which 
ultimately led to propose them as regulators of MOMP and apoptosis.  Interestingly, while 
testing them as pore-forming proteins, researchers showed that low pH triggers the membrane 
interactions of Bcl-2 protein.  Since then, in vitro studies on the membrane interactions of Bcl-xL 
are triggered by low pH [65, 84, 88, 90], although it is not clear if this is a prevailing signal that 
triggers insertion in the cell. 
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FIGURE 1.11 Structural comparison between Bcl-xL and diphtheria toxin translocation 
domain.  The two central hydrophobic helices of Bcl-xL (left) and the T domain (right) are 
shown in red, while 2 amphipathic helices are colored in yellow.  Figure taken from reference 
[66]. 
Other similarities between Bcl-xL and the T domain arise from their membrane interactions. 
First, both the soluble domain of Bcl-xL and the T domain are attached to independent domains 
that serve as anchors to the membrane: TM helix and R domain for Bcl-xL and T domain, 
respectively (See Fig. 2.2 and associated text for more details).  Hence, the membrane 
interactions of the N-terminal region of Bcl-xL are analogous to that of the T domain.  Second, it 
is suggested that the central hydrophobic helices of each protein (α5-α6 and TH8-TH9 in Bcl-xL 
and T domain, respectively) insert as transmembrane hairpins [51, 53, 57-60, 85, 96, 97].  
Finally, Bcl-xL inserts into the bilayer as a monomer [83], which is similar to the case of the 
active form of the T domain [98, 99].   
All these similarities led to suggest that the T domain would serve as a model for the 
understanding of Bcl-xL and other Bcl-2 proteins (Fig. 1.12) [64].  However, the molecular 
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details of the membrane interactions of Bcl-xL and other Bcl-2 proteins have not been studied, 
and it is unknown if they reflect what has been described for the T domain.  For example, the T 
domain inserts into the membrane following a complex pathway with multiple intermediate 
states [43].  The membrane insertion pathway of Bcl-xL has not been described, and it is 
unknown if there are any intermediate states.  In chapter 2, we show the membrane insertion 
pathway of Bcl-xL and systematically compare the features of that pathway described for the T 
domain to that determined for Bcl-xL. 
 
FIGURE 2.12 Similarities between the membrane insertion models of Bcl-xL, Bax and the 
T domain as suggested in the literature [64].  The molecular details and the validity of these 
models have not been experimentally tested.   
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MEMBRANE LIPIDS AND APOPTOSIS 
There is growing evidence suggesting that different membrane lipids play a role in the 
regulation of Bcl-2 proteins, MOMP and apoptosis [100-111].  The most common example is 
that of cardiolipin, a phospholipid that in eukaryotes is found only in mitochondrial membranes 
[8].  Cardiolipin is a phospholipid with four acyl chains, and it has two negative charges in the 
headgroup under physiological conditions [112, 113].  Cardiolipin was first linked to apoptosis 
because cells with disrupted gene CRD1, which encodes cardiolipin synthase, showed altered 
mitochondrial functions, including increased cell death [114].  Subsequent studies suggested that 
cardiolipin is depleted during cell death [104] and is required for membrane interactions of Bid, 
Bax and Bcl-xL [83, 84, 103, 115, 116].  It is unclear what unique features of cardiolipin are 
important for regulation of apoptosis.  Since some studies also have shown that the membrane 
interactions of Bcl-xL are regulated by phosphatidylglycerol [88, 90, 109], another anionic lipid, 
one possibility is that negative charges at the membrane interface are important for the action of 
the Bcl-2 proteins.  A second possibility, however, is that cardiolipin and phosphatidylglycerol 
share some other common property because phosphatidylglycerol is precursor during 
biosynthesis of cardiolipin [8].  In chapter 4, we carry a detailed physicochemical 
characterization on the role of membrane lipids in the membrane interactions of Bcl-xL. 
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SUMMARY, HYPOTHESES AND SPECIFIC AIMS 
Summary 
1) The structure of the lipid bilayer consists of a double layer of lipids, where the acyl chains 
form the hydrocarbon core and the headgroups form relatively large and chemically 
complex membrane interfacial regions at each side of the hydrocarbon core. 
2) Biological membranes are composed of an enormous variety of lipids that modulate the 
physicochemical properties of the lipid bilayer, at the hydrocarbon core and at the 
membrane interface. 
3) The only two thermodynamically permitted folds of membrane proteins are transmembrane 
α-helical bundles and β-barrels.  Penetration of non-hydrogen bonded protein backbone 
into the hydrocarbon core is associated with prohibitive free energy penalty. 
4) Membrane proteins insert into membrane by using either a translocon-assisted mechanism 
or upon receiving a cellular signal (e.g. protonation, proteolytic cleavage).  
5) The diphtheria toxin T domain inserts into the membrane under acidic conditions via a 
multi-step pathway modulated by the protonation of various titratable residues.  Initial 
stages of the refolding/insertion reaction are associated with the protonation of N-terminal 
histidines. 
6) The Bcl-2 family proteins modulate apoptosis upon interaction with the mitochondrial 
outer membrane and pore formation.  Bcl-2 proteins are structurally similar to the 
diphtheria toxin T domain and respond to acidification in vitro. 
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Hypotheses 
1) Given their functional differences, Bcl-xL and the T domain follow distinct pH-triggered 
membrane insertion pathways despite the structural similarities of their water-soluble 
states. 
2) Membrane interactions of pH-induced membrane inserting proteins can be manipulated by 
protonation of key residues in the protein. 
3) Properties of lipid bilayer modulate transmembrane insertion of proteins.  
Specific aims 
In chapter 2, we determine the membrane insertion pathway of Bcl-xL and compare it to that 
of the diphtheria toxin T domain. 
In chapter 3, we establish the effect of mutating individual C-terminal histidines on the folding 
and function of the diphtheria toxin T domain. 
In chapter 4, we establish the regulatory role of cardiolipin and a variety of lipids on the 
membrane interactions of Bcl-xL. 
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CHAPTER 2.  COMPARING pH-DEPENDENT MEMBRANE INSERTION 
PATHWAYS OF BCL-XL AND DIPHTHERIA TOXIN T DOMAIN 
INTRODUCTION 
Bcl-xL is an antiapoptotic member of the Bcl-2 family of proteins whose function is inhibiting 
the mitochondrial outer membrane permeabilization (MOMP) to prevent the cell from going into 
apoptosis [47, 73].  The mechanism by which Bcl-xL accomplishes its action is still under debate 
[75, 76, 81], although it is suggested that involves the redistribution of Bcl-xL between a 
cytosolic and a membrane-associated form [77, 80].  Given the similarities of the folded states 
between the diphtheria toxin translocation domain (T domain) and Bcl-xL (see introduction and 
below), it has been proposed that the T domain serves as model for the understanding of the 
action of Bcl-xL [64, 66] and other structurally similar Bcl-2 proteins [47] at the membrane.  
Here, we test this hypothesis by applying an array of spectroscopic methods to characterize the 
membrane insertion pathway of Bcl-xL, and compare it to that recently described for the T 
domain (Fig. 1.6) [53]. 
The diphtheria toxin is composed of three domains: the C domain (residues 1-199), the T 
domain (residues 200-378) and the R domain (residues 379-535) (Fig. 1.4A).  The C domain 
inhibits protein synthesis in the target cell; the T domain is responsible for the translocation of 
the C domain inside the cell; and the R domain is responsible for the initial attachment of the 
toxin to the target cell through a direct interaction with a membrane receptor (Fig. 1.4B) [42].  
The T domain is soluble in the aqueous extracellular fluid, but it undergoes a pH-triggered 
refolding and insertion into the endosomal membrane during endosomal acidification.  The 
membrane insertion of the T domain results in the translocation of its own N-terminus across the 
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membrane, allowing the C domain or any other protein attached to the N-terminus to cross the 
membrane [117-119].  The isolated T domain has been a choice model for numerous biophysical 
studies on membrane binding and insertion [50-53, 57-60, 63, 68, 99, 119-124].  
Bcl-xL shares significant structural and functional similarity with the diphtheria toxin T 
domain [64, 66, 85] (Fig. 2.1, detailed description in the introductory chapter).  First, the high-
resolution structure of Bcl-xL in the water-soluble state [66] shows a highly helical structure, 
with two central hydrophobic helices, α5 and α6 (red helices).  The remaining helices (grey 
helices), as in the case of the T domain, surround the hydrophobic core.  Bcl-xL, however, has an 
additional hydrophobic helix located at the C-terminus, TM helix, which is suggested to anchor 
the protein to the membrane prior to insertion [85].  Second, Bcl-xL also inserts into the bilayer 
in response to low pH [65, 84, 88, 90], although it is not clear if this is a prevailing signal that 
triggers insertion in the cell.  Third, Bcl-xL inserts into the bilayer as a monomer [83], which is 
similar to what is described for the active form of the T domain [98, 99].  Finally, although the 
high-resolution structure of the membrane-inserted state of Bcl-xL is not available, the evidence 
suggests that helices α5 and α6 insert as transmembrane regions [85, 96], like TH8-TH9 of the T 
domain, while other regions might reside in the membrane interface.  
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FIGURE 2.1 High resolution structures of the T domain and Bcl-xL.  A) Crystal structure of 
the diphtheria toxin T domain (PDB 1MDT) in solution at neutral pH [49].  The central helices 
TH8-TH9 are shown as red ribbons. B) NMR structure of Bcl-xL (PDB 1LXL) in solution [66], 
with helices α5 and α6 shown as red ribbons.  Residues used for cysteine replacement and site-
selective labeling in reference [53] (for T domain) and in this chapter for Bcl-xL are shown as 
CPK.  The putative location of the truncated C-terminal TM helix of Bcl-xL is schematized with 
a dotted arrow.   
What would be an appropriate version of Bcl-xL to be compared to the T domain with regard 
to membrane insertion?  The initial attachment of Bcl-xL to the mitochondrial membrane is 
ensured by a single TM helical fragment (residues 208-233). The folded N-terminal region (oval 
in Fig. 2.2) remains in a water-soluble state [85] and does not enter the membrane prior to the 
acidification.  This arrangement is similar to that of the diphtheria toxin, with the TM fragment 
and the N-terminal domain of Bcl-xL being equivalent to the R domain and the T domain of the 
toxin, respectively.  Therefore, most of the results presented here were generated with a Bcl-xL 
version in which the C-terminal helix has been truncated.  The comparison made in this chapter 
corresponds to the membrane insertion processes of the N-terminal domain of Bcl-xL (residues 
1-207) and the isolated T domain (residues 200-378), depicted as curved arrows in Fig. 2.2.   
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FIGURE 2.2 Schematic representation of the mode of attachment of the diphtheria toxin 
and Bcl-xL to their target membranes. The scheme illustrates the equivalent 
attachment/anchor function of the TM helix and the R-domain for Bcl-xL (A) and the diphtheria 
toxin (B), respectively.  The membrane insertion of the T domain and the N-terminal region of 
Bcl-xL occur regardless of the attachment to the membrane. The processes addressed in this 
chapter are shown as curved red arrows (see text for more).  
The truncation of the TM helix of Bcl-xL offers important additional advantages since it 
allows the study of the initial association of the protein with the membrane interface.  The FRET 
assay used in this study for measuring this association was developed, and validated using 
independent FCS measurements, for the case of the T domain [53].  The assay uses the donor in 
the protein and the acceptor attached to a lipid head group, and requires that the protein and the 
membrane interface are not within the Förster distance of the donor/acceptor pair prior to the 
interaction.  If the protein is already anchored to bilayer due to the TM helix, then the donor and 
acceptor would be within the Förster distance, and no spectral changes may be observed when 
triggering the binding of the N-terminal region of Bcl-xL to the membrane interface.  Thus, by 
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truncating TM helix, we aim to prevent the N-terminal domain of Bcl-xL to be anchored to the 
bilayer, and ensure a detectable change in fluorescent signal upon donor/acceptor interaction.   
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RESULTS 
Folding and stability of Bcl-xL in solution: truncation of TM helix 
For the reasons discussed above, we truncated the TM helix of Bcl-xL using a standard site-
directed mutagenesis that introduces a stop codon at the position 208 of the protein coding 
region.  We then determined the effect of this truncation in the folding and stability of the protein 
in solution using circular dichroism (Fig. 2.3).  Both the full-length and the truncated version of 
Bcl-xL show CD spectra that are typical of a protein with α-helical secondary structure (minima 
at 220 and 208nm and maximum towards 190nm), consistent with the high resolution structure 
of Bcl-xL [66].  Both proteins also show similar ellipticity (compare black spectra of panels A 
and B), which indicates that the truncation did not cause substantial changes in the secondary 
structure of the protein.  However, the refolding of Bcl-xL (blue spectra) after thermal unfolding 
(red spectra) was more complete in the truncated form, as judged by the recovery of CD signal 
after heating and cooling.  The thermal unfolding experiments (Panels C and D) indicate that 1) 
the truncated form is more stable than the full-length Bcl-xL, 2) reversibility is only achieved for 
the truncated form, and 3) the process is rate-independent for both proteins.  Together, these 
results indicate that Bcl-xL is less stable in solution, and possibly more prone to aggregation, 
when the TM helix is present.  Hereafter, the truncated form of Bcl-xL is referred to as Bcl-xL. 
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FIGURE 2.3 Thermal unfolding of the full-length and truncated Bcl-xL in solution at pH 8.  
Panels A (truncated) and B (full-length) show the CD spectra before (black spectra) and after 
thermal unfolding (red spectra), and after the rapid cooling to 25°C (blue spectra).  Panels C 
(truncated) and D (full-length) show the thermal unfolding of the folded (1st run, black data) and 
refolded (2nd run, blue data) Bcl-xL.  The latter panels also show the thermal unfolding at 
double rate of heating (green data).  The data suggest that reversible and rate-independent 
transitions in Bcl-xL, which are the prerequisite to quantitative analysis of thermal unfolding, 
can be achieved by deletion of the C-terminal TM helix. 
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Folding and pH-dependent stability in solution: comparison to T domain 
To determine whether or not Bcl-xL and the T domain share similar membrane insertion 
pathways, we first studied the stability of Bcl-xL at different pH.  The first transition along the 
membrane insertion pathway of the T domain occurs in solution and is pH-dependent, and 
corresponds to the conversion of the water-soluble state (W-state) into the membrane-competent 
state (W
+
-state) (Fig. 1.6) [43].  This transition is characterized by partial refolding, reduction in 
the amount of secondary structure and loss of thermostability in a pH-dependent fashion [50, 52, 
63, 124].  To determine whether the pH-triggered membrane insertion of Bcl-xL goes through 
the formation of a similar intermediate, we tested the pH-induced loss of secondary structure by 
CD spectroscopy (Fig. 2.4).  Upon acidification, the CD spectrum of Bcl-xL maintains its 
characteristic shape and exhibits marginal reduction in molar ellipticity (Panel A), indicating that 
Bcl-xL does not experience a pH-induced loss of secondary structure.  This behavior is different 
from that of the T domain (panel B), which loses substantial part of its ellipticity signal in the 
same pH range [121, 122].  . 
 
35 
 
FIGURE 2.4 pH-dependent variation in secondary structure of Bcl-xL and the T domain in 
solution.  A) CD spectra of Bcl-xL in solution at pH 8 (black spectrum), 6 (red spectrum), 5 
(blue spectrum), 4 (olive spectrum) and 3.2 (dark yellow spectrum) at 25°C.  The CD spectrum 
at pH 8 and 95°C is shown for reference (dotted line). B) pH-dependent changes in molar 
ellipticity measured at 222 nm for T domain (red symbols, data reproduced from [122] for visual 
comparison) and Bcl-xL (black symbols). 
Next, we tested the pH-induced loss of thermodynamic stability by measuring changes in 
ellipticity at 222 nm as a function of temperature.  In Fig. 2.3 we established that thermal 
unfolding of Bcl-xL is reversible and rate-independent, which are prerequisites for quantitative 
analysis.  To provide a visual reference, we display the fits for the previously published thermal 
unfolding data for the T domain [124] in Fig. 2.5.  These results indicate a substantial loss of 
stability when pH is reduced from 8 to 6, which follows from an over 15°C reduction in the 
melting temperature and a loss in transition enthalpy ΔH° (Thermodynamic parameters for the 
thermal denaturation of both proteins are summarized in Table 1).  Cooperative melting 
transition is no longer observed at pH 5, when the T domain is converted to the W
+
-state (Fig. 
2.5A, blue line).   In contrast, we observe identical thermal transitions of Bcl-xL at pH 8 and 6 
(Fig. 2.5B).  Moreover, further acidification up to pH 4 causes only a small decrease in melting 
temperature and transition enthalpy (Fig. 2.5B and Table 2.1). These results clearly indicate that 
the solution fold Bcl-xL is not destabilized by acid, complementing a previous report that 
showed Bcl-xL being equally resistant to chemical denaturation at neutral or acidic pH [89].  
Together, our measurements suggest that Bcl-xL does not go through a CD-detectable pH-
induced conformational change in the aqueous phase as does the T domain, demonstrating 
differences at the very early stages of the membrane insertion pathways. 
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FIGURE 2.5 pH-dependent variation in thermostability of Bcl-xL and the T domain in 
solution.  A) Fitting curves of the previously published data [124] on thermal unfolding of the T 
domain in solution at pH 8 and 6 are shown for reference.  At pH 5 no cooperative melting 
transition can be detected.  B) Thermal unfolding of Bcl-xL at pH 8 (black), pH 6 (red), pH 5 
(blue) and pH 4 (olive).  The figure illustrates the small effect of acidification on the thermal 
stability of Bcl-xL, contrasting with the dramatic loss of stability of the T domain. 
Corresponding thermodynamic parameters are summarized in Table 1.   
 
TABLE 2.1 Thermodynamic parameters for the thermal unfolding of the T domain and 
Bcl-xL in solution at the indicated pH. *Parameters for the T domain were published in 
reference [124]. 
pH 
T domain* Bcl-xL 
Tm, °C ΔH°, kcal/mol Tm, °C 
ΔH°, 
kcal/mol 
8 75 ± 1 95 ± 7 77 ± 1 87 ± 6 
6 59 ± 1 78 ± 6 76 ± 1 88 ± 4 
5 No cooperative transition 73 ± 1 89 ± 4 
4 No cooperative transition 70 ± 1 62 ± 8 
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Membrane association 
Previous studies have reported the pH dependence of membrane binding of the T domain to 
vesicles of various lipid compositions using several independent spectroscopic methods, which 
produced results with excellent agreement [50, 53].  One of them, based on FRET methodology, 
is used here for Bcl-xL.  Briefly, the donor dye (Alexa488) is attached to the protein and the 
acceptor (Rhodamine) is incorporated in large unilamellar vesicles (LUV) as Rhodamine-PE.  
When protein and vesicles are mixed together at various pH, the binding can be measured by the 
decrease in the emission intensity of the donor or by the shortening of its fluorescence life-time. 
We show representative results of the steady-state (Fig. 2.6A) and life-time (Fig. 2.6B) 
fluorescence measurements for membrane interaction of the Bcl-xL R102C mutant with 
selectively attached dye to the cysteine residue.  As expected, the data indicate a decrease in the 
fluorescence intensity and faster fluorescence decay when the interaction between the donor and 
acceptor is triggered by acidification (steps 1 and 2, black and blue).  Importantly, the process is 
reversible, since the spectral features are recovered upon return to pH 8 (step 3, red), allowing 
the thermodynamic treatment to the data. 
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FIGURE 2.6 Reversibility of pH-dependent membrane association of Bcl-xL examined by 
the FRET measurements between donor-labeled protein and acceptor-labeled LUV.  A) 
Emission spectra of the donor at pH 8 (step 1, black spectrum) and 4.5 (step 2, blue spectrum) in 
the presence of the acceptor.  The loss of intensity is recovered upon addition of NaOH to return 
to pH 8 (step 3, red spectrum).  B) Fluorescence decay of the donor at pH 8 (step 1, black trace) 
and 4.5 (step 2, blue trace) in the presence of the acceptor.  The shortening of the decay is 
reversed upon return to pH 8 (step 3, red trace).  The data indicate that the pH-triggered binding 
of Bcl-xL to the membrane is a reversible process.  
Before proceeding into a full characterization of the membrane association of Bcl-xL, we 
performed two control experiments.  In the first one, we measured the changes in fluorescence 
signal in the absence of acceptor-labeled membranes (Fig. 2.7A), and we did not observe any 
changes upon decrease in the pH.  Therefore, the changes observed in Fig. 2.6 are consistent with 
association of labeled Bcl-xL with the membrane rather than an effect of pH on the probe.  In the 
second control experiment, we changed the position of labeling from residue R102C to G70C or 
S110C and gradually decreased the pH (Fig. 2.7B).  The resulting pH-dependent binding profiles 
are superimposable, indicating that we can label any of the three residues with the donor dye 
without affecting membrane binding).   
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FIGURE 2.7 Effect of acidification and labeling position on spectral features of the probe 
Alexa488 attached to Bcl-xL.  A) Effect of acidification on the fluorescent signal of the 
Alexa488 attached to Bcl-xL in the absence of acceptor-labeled LUV.  Fluorescence decay was 
measured in solution at pH 8 (step 1, black trace) and pH 4.5 (step 2, red trace).  Measurement in 
the presence of acceptor-labeled LUV is shown for reference (blue trace).  B) pH-dependence of 
binding of Bcl-xL labeled at three different positions to LUV composed of POPG:POPC 3:1.  
Measurements performed result in overlapping pH-dependent binding curves. 
For the T domain, the initial binding proceeds through an interfacial intermediate I-state and is 
largely independent of the physical-chemical properties of the membrane interface [53].  We 
tested whether this would also hold true for Bcl-xL by measuring the association of the protein to 
LUV of different lipid compositions as a function of the pH.  To do so, we used the FRET assay 
described above, and we calculated the FRET efficiency of binding at different pH values.  In 
Fig. 2.8A, we show the titration curves previously reported for the case of the T domain [53], 
where it is clear that regardless of the proportion of the anionic lipid POPG in the LUV, the pK 
of the transition remains mostly unaltered.  The case of Bcl-xL (Fig. 2.8B), however, appears to 
be different.  In this case, the decrease of the POPG content causes a shift in the pK of the 
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transition, indicating that the binding of the protein to the bilayer depends on the physical-
chemical properties of the membrane interface.  Furthermore, Bcl-xL was unable to bind to LUV 
composed of only 10% anionic lipid (cyan) in the pH range studied, indicating that POPG is 
critical for binding of the protein to the membrane.  Thus, in contrast to the case of the T domain, 
our results indicate that the formation of the membrane-competent state of Bcl-xL responds to 
changes in the physical-chemical environment of the membrane interface.   
 
FIGURE 2.8 Comparison of pH-dependent binding of Bcl-xL and the T domain to LUV 
composed of different mixtures of POPC and POPG.  A) The binding of the T domain to the 
membrane interface does not depend on the mole fraction of POPG, as the three lipid 
compositions result in almost overlapping titration curves (only fitting curves taken from 
reference [53] are shown). B) The titration curves of Bcl-xL shift to a lower pH when the mole 
fraction of POPG decreases.  The pKs and n (Hill coefficient) were obtained by fitting the data to 
a two-state model as described in methods. 
This difference in the binding to the membrane interface implies that both proteins respond to 
the pH changes at different stages of the process.  In the case of the T domain, the protein would 
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respond to acidification when still in the bulk solution, because 1) the low pH causes 
conformational changes in the absence of membranes (Fig. 2.4 and 2.5, Table 2.1, and references 
[50, 52, 63, 121, 124]) and 2) binding to the bilayer does not depend on the physical-chemical 
properties of the membrane interface (Fig. 2.8 and reference [53]).  In the case of Bcl-xL, 
however, the opposite is true: 1) no changes are observed during the acidification in the absence 
of membranes (Fig. 2.4 and 2.5 and Table 2.1), and 2) there is a strong dependence on the 
content of POPG (Fig. 2.8).  The charges on the POPG head group will create a negative surface 
potential that can either affect the pK’s of key titratable groups of Bcl-xL directly or possibly 
modulate the local pH near the interface, or both [125, 126].   
Membrane insertion of the hydrophobic helical hairpin  
The next step in the insertion pathway of the T domain is an interfacial refolding and 
membrane insertion of the hydrophobic helical hairpin TH8-TH9 (Fig. 2.1A) to form a 
transmembrane T-state [53].  The formation of this state can be followed experimentally by 
attaching the environment-sensitive fluorescent probe NBD to a single-cysteine mutant in the 
middle of helix TH9 [53, 68].  A similar transition is predicted to occur for Bcl-xL, as the helices 
α5-α6 (Fig. 2.1B) have been observed to adopt a transmembrane topology in the context of the 
isolated fragments [85].  To confirm that these helices can be inserted in the context of protein, 
we labeled helix α6 at position N175C with NBD.  We show a typical measurement in Fig. 2.9, 
where the acidification of the medium in the presence of LUV (steps 1 and 2, black and blue) 
results in a 12 nm blue-shift and 7-fold increase of the intensity in the emission spectra (Panel 
A), and longer fluorescence decay (Panel B) of the NBD-labeled Bcl-xL.  The return to pH 8.0 
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causes the recovery of the spectral features and life-time decay, which indicates that this 
insertion process is reversible (step 3, red).  
In a control experiment, we measured the emission spectra of Bcl-xL labeled with NBD in the 
absence of LUV (Fig. 2.10).  The results showed that acidification caused little changes in the 
steady-state and life-time profiles, indicating that pH does not cause spectral changes of the NBD 
probe.  Therefore, data of Fig. 2.9 are consistent with the repositioning of the probe to a non-
polar environment.  The addition of membranes to the previously acidified sample resulted in the 
characteristic spectral signature of the NBD probe locating in the hydrophobic environment of 
the membrane (Fig. 10, blue data), suggesting that the membrane insertion of Bcl-xL is path-
independent. 
 
FIGURE 2.9 Membrane insertion of Bcl-xL monitored by fluorescence of the environment-
sensitive probe NBD attached to the residue N175C (the middle of helix α6).  A) Steady-state 
spectra in the presence of LUV at pH 8 (black spectrum) and 5 (blue spectrum) shows gain in 
intensity and blue shift at acidic pH, and recovery of spectral features upon return to pH 8 (red 
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spectrum).  B) Fluorescence decay of the same samples showing the lengthening of the decay at 
acidic pH. 
 
FIGURE 2.10 Effect of pH on spectral features of probe NBD selectively attached to Bcl-
xL.  Steady-state (A) and life-time (B) emission of Bcl-xL labeled at position N175C with NBD 
were measured in solution at pH 8 (step 1, black).  Acidification of the solution causes no 
changes in the fluorescence intensity, position of maximum emission, and fluorescence decay 
(step 2, red).  Addition of LUV to the previously acidified sample results in increase of emission 
intensity, blue-shift of the spectrum and longer fluorescence decay (blue).   
The pH dependence of this insertion is affected by the mole fraction of POPG in the T domain, 
where a high proportion of anionic lipid is required for the protein to adopt the T-state [53].  We 
show the fitting curves for the pH-dependence of the insertion of the T domain in Fig. 2.11A as 
reference.  We made the parallel analysis for the hairpin of Bcl-xL by using the NBD-labeled 
protein and measuring the changes in intensity as a function of the pH.  The data for Bcl-xL (Fig. 
2.11B) shows that the pH dependence varied just slightly with a decreasing mole fraction of 
POPG.  Measurements for LUV composed of 10% POPG were excluded from the analysis 
because of the lack of membrane association of Bcl-xL in the first place (see Fig. 2.8B).  The T 
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domain is fully bound to the membrane under those conditions, and lack of membrane insertion 
is due to the protein being trapped in a kinetic intermediate in the membrane interface [53, 63].  
In contrast, pH-dependencies of insertion of Bcl-xL only marginally differ from those of initial 
association, suggesting that the non-inserted state on membrane interface exists only transiently. 
Thus, the insertion of the helical hairpins also takes place by a different mechanism, where the T 
domain responds to the presence of anionic lipid for this step, but not Bcl-xL. 
 
FIGURE 2.11 Comparison of pH-dependent membrane insertion of the hydrophobic 
helical hairpins of the T domain and Bcl-xL.  A) The membrane insertion of the T domain into 
LUV, determined as a function of the pH, strongly depends on the mole fraction of POPG in the 
LUV (only fitting curves from reference [53] are shown).  B) The membrane insertion of Bcl-xL, 
studied as a function of the pH by following the changes in emission intensity at 525 nm, does 
not strongly depend on the POPG content of LUV.  Data for LUV composed of POPG:POPC 9:1 
was omitted due to lack of membrane association. 
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DISCUSSION 
We summarize our findings in Fig. 2.12, where we illustrate the comparison of the insertion 
pathways for the T domain and Bcl-xL.  The structures of the soluble W-states are similar for the 
two proteins [49, 66], featuring a pair of long hydrophobic helices in the middle of the structure 
(highlighted red in Fig. 2.1): TH8-TH9 and α5-α6 for the T domain and Bcl-xL, respectively.  
While these helices will adopt a transmembrane conformation in the final inserted T-state in both 
cases, the similarities between the two proteins end there.  For the case of the T domain (Fig. 
2.12A), the folded soluble W-state is initially converted to the low-stability membrane-
competent W
+
-state as a result of acidification in solution. This W
+
-state then interacts with the 
membrane in a manner that is independent of the properties of the membrane interface.  The 
latter indicates that the protein is ready to associate with the membrane when still in solution, 
and therefore senses the pH change within the bulk solution [50, 53].  The physiological reason 
for this feature is likely to be related to the fact that the toxin may dissociate from its receptor 
inside the endosome [127] and the T domain is no longer localized close to membrane interface.  
The pathway proceeds through a series of intermediate states, such as interfacial I-state and 
activated insertion-competent I
+
-state [53].  The final insertion to T-state is regulated by 
additional protonation on the membrane interface and by the presence of anionic lipids, 
presumably promoting formation of productive intermediates via electrostatic interactions with 
cationic groups on the T domain.  
Remarkably, the soluble W-state of Bcl-xL is not destabilized by acidification and the 
formation of the membrane-competent state does not appear to require a conformational change 
to occur in solution (Fig. 2.4 and 2.5, and Table 2.1).  Unlike in the case of the T domain, the 
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conformational switching initiating the insertion cascade requires the membrane interface and is 
modulated by the presence of anionic lipids (Fig. 2.8).  Once the protein is on the interface, the 
insertion proceeds without the requirement of additional protonation in a lipid-independent 
manner, which is again different from the behavior of the T domain (Fig. 2.11).  Thus, our study 
clearly indicates that Bcl-xL and the diphtheria toxin T domain insert into the lipid bilayer 
following different membrane insertion and protonation pathways.   
We suggest that the difference in the nature of the conformational switching in both proteins 
evolved to best serve their physiological function.  For the T domain, the robustness of delivery 
of its cargo (the catalytic domain, ultimately responsible for toxicity) requires no regulation step 
and is achieved by a single copy of the protein.  In contrast, Bcl-xL and other proteins of the Bcl-
2 family act collectively, and their function is very tightly regulated [47, 75, 76].  Subsequently, 
lipid-dependent triggering of the insertion (Fig. 2.8) can be a part of such regulatory machinery.  
Another important aspect of membrane interactions of Bcl-xL is the complete reversibility of 
binding (Fig. 2.6) and insertion (Fig. 2.9), also suggested previously [90], which may be required 
for proper functioning of this protein.  
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FIGURE 2.12 Schematic representations of the pH-triggered membrane insertion 
pathways of the diphtheria toxin T domain and apoptotic regulator Bcl-xL.  Each starts with 
a similarly folded soluble W-state (Fig. 2.1) and ends with membrane-inserted T-state, in which 
two central hydrophobic helices, TH8-TH9 of the T domain and α5-α6 of the Bcl-xL, adopt a 
transmembrane conformation.  The pathway connecting the two states, however, is very different 
in the two proteins.  T domain goes through a set of intermediate states and undergoes several 
protonation transitions, both in solution and on membrane interface, characterized by staggered 
pH-dependencies [53].  Unlike the T domain, Bcl-xL is not destabilized by acidic pH in solution, 
and protonation resulting in the formation of its membrane-competent form occurs on membrane 
interface where it can be regulated by lipid composition.  The interfacial intermediate state for 
Bcl-xL appears to be transient (as indicated by dotted border line of I-state on the scheme) with 
insertion closely following initial association with membrane interface (see Figs. 2.8 and 2.11, 
and text for details). 
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MATERIALS AND METHODS 
Materials: Palmitoyl-oleoyl-phosphatidylcholine (POPC), palmitoyl-oleoyl-
phosphatidylglycerol (POPG) and Rhodamine-PE were purchased from Avanti Polar Lipids 
(Alabaster, AL).  IANBD-ester and AlexaFluor488-maleimide were obtained from Invitrogen 
(Carlsbad, CA). 
Cloning and mutagenesis: Full-length Bcl-xL (residues 1-233) was PCR-amplified from 
cDNA obtained from K562 human lymphoma cells and ligated into the pET28b vector using the 
NdeI and EcoRI cloning sites.  The truncated version of Bcl-xL (residues 1-207) was generated 
by introducing a stop codon in the position corresponding to residue 208.  For the purposes of 
Cys-labeling with fluorescent dyes, Cys-less mutant (C151S) was created and used as template 
for site-directed mutagenesis. All the constructs contained an N-terminal 6xHis-tag for 
purification.   
Expression, purification and labeling: The expression and purification of Bcl-xL was based on 
the previously described procedure for the pET system [128].  Briefly, BL-DE23pLysE E.coli 
cells were transformed with the corresponding pET plasmid and grown to OD600nm ~ 0.6, after 
which expression was induced by addition of 0.8M IPTG and the cells grown for an additional 
16 hours at 24°C.  The cells were pelleted by centrifugation, lysed by sonication and clarified by 
centrifugation for 30 min at 4000 rpm and 4°C.  The proteins were then incubated with Ni-NTA 
beads, washed with washing buffer (50mM Tris-HCl, 300mM NaCl, 5mM imidazole, pH 8) and 
eluted with 0.5M imidazole in the same buffer.  The eluted proteins were subjected to size-
exclusion chromatography on a Sepharose12 1x30cm column in 50mM phosphate buffer at pH 
8, and quantified by measuring their absorbance spectra in the range 200-350 nm (we used molar 
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extinction coefficient of 41,200 M
-1
cm
-1
 at 280 nm).  Labeling with fluorescent dyes was 
performed using a standard procedure for thiol-reactive derivatives [53, 129] and the unreacted 
dye was removed by gel filtration chromatography in the same column and buffer. 
LUV preparation: Large unilamellar vesicles (LUV) containing molar mixtures POPG:POPC 
(3:1, 1:3 and 1:9) of 0.1 µm diameter were prepared by extrusion as previously described [130, 
131].  Rhodamine-labeled LUV were prepared by the addition of 2% of Rhodamine-PE to the 
lipid mixture. 
Circular dichroism and thermal unfolding: CD measurements were performed using an 
upgraded Jasco-720 spectropolarimeter (Japan Spectroscopic Company, Tokyo). Normally, 100 
scans were recorded between 190 and 260 nm with a 1 nm step at 25ºC and 95ºC using a 1 mm 
optical path cuvette. The sample contained 4µM of Bcl-xL in 50mM phosphate buffer at pH 8.0 
or a mixture of phosphate and acetic/acetate buffer at pH 6.0, 5.0 or 4.0.  Further acidification 
was reached by equilibrating the sample in 50mM glycine-HCl buffer. All spectra were corrected 
for background.  The thermal unfolding was followed at 222 nm with a 1 degree/minute scan 
rate, unless indicated.  The data was fitted to a two-state transition as described before [68, 124], 
obtaining the transition temperature Tm and transition enthalpy ΔH° with the following 
equations:  
)X)(TmY(X)TmY(Y NUUNNN  1     (Eq. 2.1) 
)]RT/)Tm/T(Hexp(/[X N  111
      (Eq. 2.2) 
where Y is the experimentally observed CD signal at a given temperature, YN and YU represent 
the signals of the pure native and unfolded state at 0K, and mN and mU are the temperature-
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dependencies of these CD signals for the native and unfolded states, respectively, and XN is the 
fraction of the native state at temperature T.  
Fluorescence measurements and analysis: Steady-state fluorescence emission was measured 
using a SPEX Fluorolog FL3-22 steady-state fluorescence spectrometer (Jobin Yvon, Edison, 
NJ) equipped with double-grating excitation and emission monochromators.  The measurements 
were made in a 2x10 mm cuvette oriented perpendicular to the excitation beam and maintained 
at 25ºC using a Peltier device from Quantum Northwest (Spokane, WA) in 1 nm steps.  For 
Alexa488 measurements, we recorded the emission spectra from 470 to 700 nm with excitation 
wavelength of 455 nm and slits of 2 nm for both excitation and emission.  For NBD 
measurements, we collected the emission spectra from 490 to 700 nm, and the excitation 
wavelength was 470 nm, using slits of 5 nm on both monochromators.  For each spectrum, we 
averaged 5 scans after incubating the samples during 30 min for equilibration. 
Fluorescence decays were measured with a time-resolved fluorescence spectrometer, FluoTime 
200 (PicoQuant, Berlin, Germany), using a standard time-correlated single-photon counting 
scheme as previously described [132].  Samples were excited at 440 nm by a subnanosecond 
pulsed diode laser, LDH 440 (PicoQuant, Berlin, Germany), with a repetition rate of 10 MHz.  
Fluorescence emission was detected at 535 nm, selected by a Sciencetech Model 9030 
monochromator, using a PMA-182 photomultiplier (PicoQuant, Berlin, Germany).  The samples 
normally contained 0.3μM protein and 0.5mM lipid.  The fluorescence intensity decay was 
analyzed using FluoFit iterative-fitting software based on the Marquardt algorithm (PicoQuant, 
Berlin, Germany). 
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The pH-dependencies of the fraction of membrane-bound or membrane-inserted states 
generated by corresponding spectroscopic experiments (F) were fitted to the following equation 
[133]: 
)pKpH(n
F


101
1
        (Eq. 2.3) 
where pK is a negative logarithm of the dissociation constant, and n is the Hill coefficient. 
Data analysis and illustrations: Data analysis, fittings and preparation of graphs were 
performed with the commercial software packages OriginPro versions 8.5, 9.0, 9.1 and 2015 
(OriginLab Corporation, Northampton, MA).  Structural visualization and preparation of 
illustrations were performed with DS Viewer 6.0 and Discovery Studio 4.1 (Accelrys Software 
Inc., San Diego, CA) 
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CHAPTER 3 ROLE OF C-TERMINAL HISTIDINES IN THE MEMBRANE 
INSERTION OF THE DIPHTHERIA TOXIN T DOMAIN 
INTRODUCTION 
Diphtheria toxin, like many other bacterial toxins [42, 134-136], enters the cell via the 
endosomal pathway of internalization, where a set of environment-induced conformational 
changes result in the delivery of its active moiety into the cytosol.  The toxin is composed of 
three domains (Fig. 1.4A): the receptor-binding domain (R domain), the translocation domain (T 
domain) and the catalytic domain (C domain).  The general mechanism of toxin’s entry is shown 
in the introductory chapter of this manuscript (Fig. 1.4B), where the attachment of the R domain 
to its receptor in the plasma membrane induces the endocytosis of the toxin.  The acidification of 
the endosomal lumen in the subsequent step triggers a series of conformational changes in the T 
domain, which refolds and inserts into the membrane, and translocates the catalytic domain 
attached to its N-terminus [42, 43].  This chapter focuses on the pH-triggered membrane 
insertion and refolding of the translocation domain, particularly at the role of three histidine 
residues of C-terminal location. 
The pH-triggered membrane insertion of the T domain occurs through a multistep mechanism 
[53], with intermediate states populated in solution and in the membrane (Fig. 1.6).  The first 
step is a pH-induced refolding in solution, where a membrane-incompetent state (W-state) is 
converted into a membrane-competent state (W
+
-state).  The second step is the partitioning of the 
W
+
-state into the membrane interface to form the interfacial state (I-state).  The fate of the T 
domain in the membrane is determined by the lipid composition: a low mole fraction of anionic 
lipids results in the T domain being kinetically trapped in the I-state, while a high mole fraction 
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of negatively charged lipids promotes the formation of the final functional transmembrane state 
(T state, also known as open-channel state or OCS).  
The high resolution structure of the W-state (determined in solution at neutral pH [49]) 
consists of nine alpha helices arranged in a globular fold (Fig. 3.1).  Helices TH8 and TH9 (red 
ribbons) form the central hydrophobic core of the domain, while the remaining helices surround 
them.  High resolution structures for the other states are not yet available through experimental 
techniques.  However, that of the W
+
-state was recently modeled through molecular dynamic 
simulations and validated with spectroscopic techniques, consisting in a rearrangement of the 
structure that retains the overall globular fold of the protein (details can be found in reference 
[50]).  For the topography of the T domain in the membrane, multiple studies suggest that helices 
TH8-TH9 and possibly TH5 become transmembrane [51, 57-59, 97], while the remaining helices 
take a variety of topologies depending on the intermediate [59, 60, 97, 137].  Therefore, 
identifying mutations capable of altering the insertion pathway provides not only insights into 
the nature of acid-induced conformational switching, but also potential for future high-resolution 
studies of key intermediates.  
It has been suggested that the pH-triggered membrane insertion of the T domain is modulated 
by protonation of the six histidines residues in various stages of the process [43, 67].  Based on 
their location in the protein, these histidine residues are classified as the N-terminal (H223, H251 
and H257) and C-terminal (H322, H323 and H372) cluster of histidines.  Protonation of H223 
and H257 has been linked to the early stages of the conformational switching, involving the 
destabilization of the folded structure of the T domain in solution and the formation of the 
membrane-competent state [50, 52].  The role of the C-terminal cluster of histidines, flanking the 
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consensus insertion unit TH8-TH9 (Fig. 3.1), is less clear.  Based on an approach that combined 
site-directed mutagenesis and spectroscopic and functional assays, it was demonstrated that the 
triple replacement of all C-terminal histidines to either arginine or glutamine greatly decreases 
the translocation and impaired the formation of the OCS [68].  However, the transmembrane 
insertion of the TH8-TH9 helical hairpin was not affected.  This suggests that the transmembrane 
insertion of the T domain can be uncoupled from the translocation of its N-terminus and 
formation of an open-channel state. 
 
FIGURE 3.1 Crystal structure of the T domain showing the consensus insertion unit TH8-
TH9 and the C-terminal histidines.  Histidine residues H322, H323 and H372 are presented 
red, blue and green sticks, respectively.  Tryptophan residues W206 and W281 are shown as dark 
yellow CPK. 
This chapter focuses in the further investigation of the role of the C-terminal histidines in the 
membrane interactions of the T domain.  It specifically addresses two open questions left by the 
study of Rodnin et al. [68]:  1) why does the replacement of C-terminal histidines result in a loss 
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of activity despite the apparently normal interactions with the lipid bilayer, and 2) are any of the 
three histidines more important than the other, or will single and double replacements show a 
cumulative effect?  To answer these questions, we generated a series of mutants that mimic the 
either protonated or deprotonated state of the residues.  We use spectroscopic assays to 
determine mutation-induced changes along the membrane insertion pathway of the T domain, 
and functional assays to establish the ability of the mutants to fold into a functional open-channel 
state.  
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RESULTS 
First, we generated single mutations in the T domain to determine if the protonation of any of 
these histidines alone is responsible for the loss of function reported in the literature [68].  The 
residues were replaced by either glutamine or lysine because these residues are neutral or 
positively charged, respectively, at the pH range tested in this study.  Hence, these mutations are 
expected to mimic the non-protonated and protonated states of histidines.  Then, we tested the 
activity of single mutants by measuring the conductance in planar lipid bilayers
1
 as described 
previously [68, 118, 138].  As shown in Table 3.1 (full set of conductance measurements can be 
found in reference [124]), the relative activity of the T domain is decreased in all the mutants.  
However, the mutations of H322 resulted in the most dramatic effect, as the activities of both 
mutants H322Q and H322K were almost two orders of magnitude lower than that of the WT 
protein.  The effect of substituting H323 and H372 was less pronounced, resulting in relative 
activities within a factor of four of that of the WT protein.  These results suggest that each of the 
three C-terminal histidines affects the formation of the OCS, but the role of H322 appears to be 
critical.  We then moved on the characterization of membrane interactions of the mutants. 
 
 
 
 
                                                 
1
 Conductance measurements were performed by our collaborators at the Department of Physiology and Biophysics, 
Albert Einstein College of Medicine, Bronx, New York.  We are thankful to Dr. Paul Kienker and Dr. Alan 
Finkelstein for complementing this study. 
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T domain mutant Relative Activity 
WT 1 
H322K 0.028 ± 0.004 
H322Q 0.011 ± 0.005 
H323K 0.38 ± 0.06 
H323Q 0.26 ± 0.04 
H372K 0.83 ± 0.09 
H372Q 0.41 ± 0.04 
H322,323Q 0.007 
H322,323,372Q 0.002 
TABLE 3.1 Relative activities of the C-terminal histidine mutants of the diphtheria toxin T 
domain.  The values are calculated relative to the total increase of conductance of the WT. For 
the single replacements, the values correspond to the average and standard deviation of 3 
independent assays. 
The first step in the membrane insertion pathway of the T domain corresponds to the 
conformational switching between the W-state and the W
+
-state (Fig. 1.6) [43].  The structural 
changes have been shown by MD simulations [50], and experimentally through differences in 
thermodynamic stability [63].  We examined the stability of the WT and mutant proteins by 
measuring temperature-dependent changes in ellipticity using CD spectroscopy.  Data collected 
at pH 8 and 6 (Fig. 3.2), corresponding to the W and W
+
 states, respectively, indicate a very 
similar behavior for all proteins.  Mild acidification results in similar reduction in transition 
temperature and enthalpy (Table 3.2).  No reproducible data, however, could be collected at 
lower pH as protein aggregation in the denatured state renders thermodynamic analysis 
impossible [63, 99, 121].  Nevertheless, it is clear that the reason for the loss of functional 
activity due to histidine replacements is not associated with changes in stability in solution, but is 
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rather related to altered interactions with the membranes at some point along the insertion 
pathway. 
 
FIGURE 3.2 Thermal stability of mutants H322Q, H323Q and H372Q at pH 8 and pH 6.  
Data at pH 8 (solid symbols) and pH 6 (open symbols) indicate that replacement of C-terminal 
histidines does not alter the acid destabilization process in solution.  The thermal unfolding was 
monitored by circular dichroism.  The temperature-dependent loss of ellipticity at 222 nm was 
fitted to a two-state unfolding transition as described in the methods section (thermodynamic 
parameters are summarized in Table 2.2).  
T domain mutant 
pH 8 pH 6 
ΔH°, kcal/mol Tm, °C ΔH°, kcal/mol Tm, °C 
WT 95 ± 7 74.6 ± 0.4 78 ± 6 58.4 ± 0.4 
H322K 82 ± 6 74.2 ± 0.3 85 ± 6 57.7 ± 0.2 
H322Q 84 ± 5 75.4 ± 0.3 74 ± 7 57.4 ± 0.4 
H323K 93 ± 8 74.1 ± 0.1 88 ± 4 56.8 ± 0.6 
H323Q 82 ± 5 75.2 ± 0.4 85 ± 5 59.2 ± 0.5 
H372K 94 ± 8 74.3 ± 0.3 87 ± 7 59.0 ± 0.3 
H372Q 87 ± 4 75.1 ± 0.2 90 ± 8 56.9 ± 0.2 
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TABLE 3.2 Thermodynamic parameters derived from the fitting of thermal unfolding data 
of mutants of T domain.  Data presented correspond to single C-terminal histidine mutants and 
WT T domain for soluble state (pH 8) and membrane-competent state (pH 6). 
Previously, it was demonstrated that triple substitutions of C-terminal histidines do not prevent 
efficient insertion of the TH8-TH9 helical hairpin [68] (purple helices in Fig. 3.1), suggesting 
that they affect proper insertion of the rest of the structure.  Here we follow up on this result 
using intrinsic fluorescence from W206 and W281, located in the N-terminal helices TH1 and 
TH5, respectively (shown in dark yellow in Fig. 3.1).  Representative examples of fluorescence 
spectra of the WT and mutant H322Q in the presence of large unilamellar vesicles are shown as 
open symbols in Fig. 3.3.  Although the spectra in the membrane-incompetent W-state are 
superimposable (panel A), there is a pronounced difference when the WT and the mutant interact 
with the membrane (panel B).  Fluorescence spectra were fitted to a log-normal distribution (fits 
are shown as solid lines) as described in methods.  This procedure allows for accurate and 
reliable measurements of subtle changes in tryptophan spectral position [139].  
 
60 
 
FIGURE 3.3 Tryptophan spectra of WT and H322Q mutant in the presence of LUV at pH 
8 and pH 5.3. Panels A and B correspond to recordings at pH 8 and 5.3, respectively.  All 
spectra (open symbols) were corrected for background, normalized to maximal intensity for 
visual comparison of spectral changes and fitted to a log-normal function (lines) [139] to 
estimate the position of maximum.  
The analysis of the position of maximum emission as a function of the pH indicates that 
mutants of H322, the least active mutants (Table 3.1), experience a pH-dependent red spectral 
shift in solution (Fig. 3.4A).  A red-shift is normally associated with increased exposure of 
tryptophans to the aqueous phase [52, 139].  The magnitude of the red-shift is similar for the 
mutants and the WT, complementing our thermal stability CD results and confirming that the 
mutations do not alter either of the conformations of the T domain in solution.  On the other 
hand, both mutants show a distinct red-shift of emission in the presence of large unilamellar 
vesicles (LUV) that is not observed for the WT T domain (Fig. 3.4B), suggesting a membrane-
induced misfolding of intermediate states on the path toward the OCS.  These changes are 
detected at all lipid compositions that we tested, and appear to be exactly the same for 3:1 
mixtures of anionic:neutral lipids, regardless of the substitution of phosphatidylcholine (POPC) 
with phosphatidylethanolamine (POPE), or phosphatidylglycerol (POPG) with 
phosphatidylserine (POPS) (Fig. 3.4C).  At lower anionic content, the same effect is observed, 
but the curves are shifted to more acidic pH (Fig. 3.4D).  Thus, our results suggest that mutants 
H322K and H322Q misfold within the membrane regardless of the membrane composition. 
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FIGURE 3.4 Membrane-induced misfolding of T domain’s mutants of H322 followed by 
tryptophan fluorescence.  A and B) Position of maximum emission as a function of pH for WT 
and mutants H322Q and H322K in the absence of LUV (A), or in the presence of POPG:POPC 
3:1 LUV (B).  Membranes induce a distinct red-shift of tryptophan emission spectra for the 
mutants at pH 6-6.5.  Further acidification induces blue-shift of the spectra for the WT and 
mutant.  C and D) Position of maximum emission as function of pH for WT and the mutant 
H322Q in the presence of LUV composed of POPG:POPC 3:1, POPG:POPE 3:1 and 
POPS:POPC 3:1 (C), and POPG:POPC 1:3 (D).  Membrane-induced misfolding of mutant 
H322Q is observed regardless of the membrane composition.  Error bars represent the standard 
deviation of at least three independent measurements. 
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Next, we recorded the tryptophan emission spectra in the presence of LUV for the rest of the 
mutants, including a double and triple glutamine replacement (Fig. 3.5A).  As in the case of the 
inactive mutant H322Q, most mutants undergo a membrane-induced red shift at pH 6.0-6.5.  
However, some mutants also undergo a blue-shift under more acidic conditions, which is the 
characteristic spectral signature of the WT protein.  These results suggest that mutants of H323 
and H372 (blue and green symbols), but none of the mutants of H322 (red, orange and magenta 
symbols), partially regain the WT-like spectroscopic signature at pH 5.3.  Notably, these results 
correlate with the electrophysiological measurements of conductance (Table 3.1).  Those mutants 
experiencing a WT-like refolding in the membrane are relatively active in electrophysiological 
measurements (black box), while those that do not are the least active (red box).  We do not 
discard a blue-shift in the fluorescence spectra of the inactive mutants under even more acidic 
conditions; however, this will not be physiologically relevant.  These results suggest that the 
membrane-induce misfolding is connected to the open-channel function of the T domain.  
To confirm that the inactive mutants indeed adopt a misfolded conformation within the bilayer, 
we recorded the CD spectra of the T domain WT and the active and inactive mutants in the 
presence of LUV (POPG:POPC 3:1) at pH 5.3 (Fig. 3.5B).  The CD spectra of the membrane-
inserted state of the WT protein (black spectrum) and the active mutant H372Q (green spectrum) 
are identical and exhibit the characteristics of an α-helical structure, with minima at 222 and 208 
nm.  In contrast, inactive mutants H322Q (red spectrum), H322,323Q (orange spectrum) and 
H322,323,372Q (magenta spectrum) showed CD spectra with loss of ellipticity and atypical 
changes in shape.  These changes have been previously associated with misfolding and 
aggregation of membrane proteins [140, 141], suggesting that mutants of H322 do not fold into a 
WT-like structure in the membrane.  The relatively active mutant, H323Q (blue spectrum), does 
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not follow this pattern; it has a similar CD spectrum to that of the inactive mutant H322Q.  
Fluorescence data indicate that H323Q is strongly misfolded at the intermediate pH of 6.0, yet 
inserts like the WT at pH 5.3.  The likely reason why it cannot regain a proper fold under the 
conditions of the CD experiment is that the latter requires much higher concentrations than those 
used in fluorescence or conductance measurements.  Indeed, when the concentration of this 
mutant in the tryptophan fluorescence assay was increased, the spectrum no longer returned to 
the WT position (data not shown).   
 
FIGURE 3.5 Membrane-induced misfolding of C-terminal histidine mutants correlates 
with loss of function.  A) Position of maximum emission as function of the pH for mutants 
carrying histidine-to-glutamine mutations.  Mutants experiencing a WT-like spectral blue-shift at 
pH 5.3 (reference is spectrum at pH 8) are active in electrophysiology measurements (Table 3.1).  
Data for active and inactive mutants are shown in a black or red box, respectively.  The error 
bars represent the standard deviation of three independent measurements.  B) CD spectra of T 
domain WT and active and inactive mutants at pH 5.3 in the presence of LUV.  The inactive 
mutants show atypical CD spectral shape and decreased ellipticity.  
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DISCUSSION 
Previous studies have demonstrated that histidine protonation plays a role in the pH-triggered 
membrane insertion of the diphtheria toxin T domain [50, 52, 67, 68].  In the case of the C-
terminal cluster of histidines (H322, H323 and H372), the triple replacement to arginine or 
glutamine was shown to cause loss of translocation activity and channel formation [68].  
However, there were no apparent changes in the membrane interactions of those triple mutants, 
as judged by the unaffected transmembrane insertion of TH8-TH9, suggesting that the membrane 
action of the T domain is uncoupled from the transmembrane insertion of the helical hairpin.  
Here, we have answered two immediate questions regarding the role of this cluster of histidines 
on the membrane action of the T domain.  First, we determined that protonation of the three 
histidines modulate the activity of the T domain, but H322 appears to be the most crucial.  
Second, we found that the loss of activity of T domain correlates with misfolding within the 
membrane of the N-terminal helices, rather than TH8-TH9.  This type of conformational 
switching is clearly different from that occurring in solution and involving the protonation of N-
terminal histidines [50, 52], which is required for the formation of a membrane competent state.   
We illustrate our findings in the scheme of Fig. 3.6, which summarizes the membrane insertion 
pathway of the T domain WT (upper panel) and the mutants carrying substitutions of the C-
terminal histidines (lower panel).  Upon initial formation of the membrane-competent state and 
binding to the membrane (omitted in the scheme for simplicity), the process continues through 
the insertion of TH8-TH9 into the bilayer and the subsequent refolding of the rest of the protein 
until reaching the open-channel state [53].  In the case of the WT protein, we propose that the C-
terminal histidines are involved in guiding the conformation of the N-terminal helices through 
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productive folding intermediate states towards the OCS.  The WT protein also shows a 
characteristic closing of the channels by the N-terminal His-tag when a negative potential is 
applied [51].  Since the mutants show the same behavior [124], including the least active 
mutants, it is likely that the loss of function is associated with reduction in the number of 
channels rather than in the properties of the channels.  Thus, when C-terminal histidines are 
replaced, the protein still undergoes a proper pH-dependent destabilization in solution (Fig. 3.2), 
binds to membranes and inserts a TH8-TH9 helical hairpin [68].  Histidine replacement, 
however, leads to the formation of an intermediate that is not productive for formation of open-
channels.  This non-productive intermediate is characterized by greater exposure of W206 (TH1) 
or W281 (TH5) to the aqueous phase at pH values of ~6-6.5, manifesting itself in red-shifted 
fluorescence spectra (Figs. 3.4 and 3.5), which then aggregates in the interface. Previously we 
demonstrated that non-inserted intermediates of another protein that undergoes pH-dependent 
membrane insertion, annexin B12, are prone to aggregation on the interfaces [126, 142].   
There is no high resolution structure of the OCS available (or that of any membrane-associated 
intermediate).  Electrophysiological data, however, are consistent with helices TH8, TH9 and 
TH5 adopting a transmembrane conformation [51], where proper folding of TH5 is required for 
channel formation.  We hypothesize that protonation of C-terminal histidines regulate the 
membrane interactions leading to proper folding of helix TH5.  Since W281 is located in the 
middle TH5, its abnormal membrane penetration would explain the red-shift observed in Figs. 
3.4 and 3.5 for the inactive mutants.  This abnormal folding of TH5 has indeed been observed 
using quenchers attached to the acyl chains of membrane lipids: W281 penetration was shallow 
upon triple replacement of the C-terminal histidines (C.Ghatak, M.V.Rodnin and A.S.Ladokhin, 
unpublished data). 
66 
 
 
FIGURE 3.6 Model of the role of the C-terminal histidines in the refolding process of the T 
domain within the bilayer.  Top (WT): Upon initial destabilization of the protein and 
association with the lipid bilayer, the N-terminal region of the protein adopts a conformation that 
leads to the insertion of the TH8-TH9 unit into the bilayer.  The N-terminal region refolds to 
form the OCS.  Bottom (mutants with C-terminal histidine replacements): Membrane interaction 
of these mutants results in a different membrane conformation from that of the WT, specifically 
in the more exposed N-terminal helices.  While the insertion of TH8-TH9 is not compromised 
[68], replacement of C-terminal histidines, especially that of H322, affects the efficient folding 
of the T domain into the OCS.  
The replacement of H322 appears to be particularly damaging, with mutants H322Q and 
H322K showing the least channel activity (Table 3.1) and also misfolding on the membrane 
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(Figs. 3.4 and 3.5).  Interestingly, the replacement of H322 with the charged lysine or neutral 
glutamine has a similar effect on the folding pathway (Fig. 3.4). This is different from 
replacements of another critical residue, H257, involved in destabilization of the folded structure 
in solution [52]: while replacement with a charged residue promoted unfolding, replacement with 
a neutral residue slowed it down.  Thus, we propose that the C-terminal histidines play a crucial 
role in guiding the folding of the N-terminal region into the OCS, where the residue H322 would 
have particular importance that likely goes beyond its mere protonation.  It is possible that the 
changes in protonation of the C-terminal histidines are required to occur on a very specific step 
or multiple protonation/deprotonation cycles may take place.   
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MATERIALS AND METHODS 
Materials: POPC, POPG, POPS and POPE were purchased from Avanti Polar Lipids 
(Alabaster, AL).  Diphtheria toxin T domain (amino acids 202-378) was cloned into NdeI-
EcoRI-treated pET15b vector containing an N-terminal 6xHis-tag and a thrombin cleavage site.  
Both the mutants and the WT protein were expressed and purified as described in [121].  Briefly, 
BL-DE23pLysE E.coli cells were transformed with the plasmid and grown to OD600nm ~ 0.6, 
after which expression was induced by addition of 0.8M IPTG and the cells grown for an 
additional 16 hours at 24°C.  Cells were pelleted by centrifugation, lysed by sonication and 
clarified by centrifugation for 30 min at 4000 rpm and 4°C.  The proteins were then incubated 
with Ni-NTA beads, washed with washing buffer (50mM Tris-HCl, 300mM NaCl, 5mM 
imidazole, pH 8) and eluted with 0.5M imidazole in the same buffer.  The eluted proteins were 
subjected to size-exclusion chromatography on a Sepharose12 1x30cm column in 50mM 
phosphate buffer at pH 8, and quantified by measuring their absorbance spectra in the range 200-
350 nm (we used molar extinction coefficient of 17000 M
-1
cm
-1
 at 280 nm). 
Conductance assays in planar bilayers:  The current response was measured under voltage-
clamp conditions in planar phospholipid bilayers separating two compartments: the cis 
compartment with acidic buffer into which the proteins were injected from a stock solution and 
the trans compartment with neutral buffer, as previously described [118].  Asolectin planar 
bilayers were formed and voltage-clamp recordings were performed as previously described 
[138].  The voltage is defined as the potential of the cis compartment, relative to that of the 
opposite trans compartment. Both aqueous solutions contained 1 M KCl, 2 mM CaCl2 , and 1 
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mM EDTA; in addition, the cis compartment contained 20 mM malic acid, pH 5.3, and the trans 
compartment contained 20 mM HEPES, pH 7.2. 
LUV preparation: Large unilamellar vesicles (LUV) of 0.1 µm diameter were prepared by 
extrusion as previously described [130, 131]. The vesicles were composed of molar mixtures of 
POPG:POPC 3:1, POPG:POPC 1:3, POPG:POPE 3:1, and POPS:POPC 3:1. 
Tryptophan fluorescence measurements:  Fluorescence was measured using a SPEX Fluorolog 
FL3-22 steady-state fluorescence spectrometer (Jobin Yvon, Edison, NJ) equipped with double-
grating.  The measurements were made at 25ºC in 2x10 mm cuvettes oriented perpendicular to 
the excitation beam.  Tryptophan residues were excited at 280 nm and the emission spectra were 
recorded between 290-500 nm using excitation and emission spectral slits of 2 and 4 nm, 
respectively.  Normally, we added purified T domain WT or mutant from a concentrated stock to 
50 mM of sodium phosphate buffer at pH 8.0.  We mixed the sample with LUV to reach final 
concentrations of 1 µM and 1 mM of T domain and LUV, respectively, and rapid acidification 
was achieved by addition of small amounts of concentrated acetic buffer.  We recorded at least 5 
scans after an incubation time of 30 min to assure the equilibration of the sample.  All spectra 
were corrected for background and fitted to a log-normal distribution as described in [139] with 
the following equations to determine the position of maximum of emission: 
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while for 
12 




 max ,   0I ,     (Eq. 3.1) 
where I0 is the intensity observed at the wavelength of maximum intensity λmax, and Γ is the 
full width of the spectrum at half-maximum intensity.  The asymmetry of the distribution is 
described by the parameter ρ.  Normally, positions of maximum for 3 to 6 samples were 
averaged.  
CD measurements and analysis of thermal unfolding: CD measurements were performed using 
an upgraded Jasco-720 spectropolarimeter (Japan Spectroscopic Company, Tokyo). Normally, 
100 scans were recorded between 190 and 260 nm with a 1 nm step at 25ºC, using a 1 mm 
optical path cuvette. The sample contained 4 µM of T domain, either WT or mutant, and 1 mM 
of LUV in 50 mM phosphate buffer at pH 8.0. The rapid acidification was reached as described 
in the fluorescence experiments. All spectra were corrected for background; however, only the 
data collected at wavelengths longer than 200 nm, where effects of scattering are negligible 
[143], were presented.  
For the thermal unfolding measurements, the ellipticity was measured at 222 nm with a 1 
degree/minute scan rate.  The analysis of thermal stability, yielding transition temperature Tm 
and transition enthalpy ΔH°, was performed by fitting the data to a two-state transition as 
previously described [68, 121] with the following equations [144]: 
)X)(TmY(X)TmY(Y NUUNNN  1     (Eq. 3.2) 
)]RT/)Tm/T(Hexp(/[X N  111
      (Eq. 3.3) 
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where Y is the experimentally observed CD signal at a given temperature, YN and YU represent 
the signals of the pure native and unfolded state at 0K, and mN and mU are the temperature-
dependencies of these CD signals for the native and unfolded states, respectively, and XN is the 
fraction of the native state at temperature T.  
Software for data analysis: Data analysis, fittings and figure preparation were performed with 
commercial software packages OriginPro versions 8.5 and higher (OriginLab Corporation, 
Northampton, MA).  Structural visualization and preparation of figures were performed with DS 
Viewer 6.0 and Discovery Studio 4.1 (Accelrys Software Inc., San Diego, CA). 
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CHAPTER 4  REGULATION OF THE MEMBRANE INTERACTIONS OF BCL-XL BY 
LIPIDS 
INTRODUCTION 
The Bcl-2 family of proteins control the mitochondrial outer membrane permeabilization 
(MOMP) during apoptosis [47].  The process is considered as the point of no return in cell death 
because it irreversibly releases mitochondrial proteins (e.g. cytochrome C and SMACs) into the 
cytosol, activating a cascade of caspases that execute apoptosis [71, 73].  The Bcl-2 family of 
proteins are subdivided into three classes [74]:  the pro-apoptotic (e.g. Bax, Bak), which promote 
MOMP; the anti-apoptotic (e.g. Bcl-xL, Bcl-2), which prevents MOMP; and the BH3-only (e.g. 
Bid, Bim), which either inhibit anti-apoptotic members or activate pro-apoptotic members.  The 
mode of action of the Bcl-2 family of proteins is a matter of active debate, and the molecular 
mechanism is not clearly understood.  The current models acknowledge that the mitochondrial 
outer membrane is a critical platform for Bcl-2 proteins’ action [75, 76, 81, 145], however the 
role of specific lipids and properties of the membrane itself have not been characterized.  Here, 
we test the effect of various lipids of biological relevance on the membrane interactions of the 
anti-apoptotic protein Bcl-xL. 
In vivo, Bcl-xL exists in at least two forms: soluble in the aqueous environment of the cytosol, 
and bound to the mitochondrial outer membrane.  It is suggested that the dynamic exchange 
between these two forms (i.e. membrane association and dissociation) is part of the mechanism 
of action of Bcl-xL [77, 78, 80, 83, 146].  The high resolution structure of the water-soluble 
conformation is known [66], and consists of globular arrangement of α-helices, with helices α5-
α6 at the hydrophobic core (colored in red in Fig. 4.1).  In contrast, the high resolution structure 
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of the membrane-bound state of Bcl-xL is unknown, but it is suggested that helices α5, α6 and 
the TM helix adopt a transmembrane topology [85].  In vitro, the membrane association of Bcl-
xL can be triggered by low pH [65, 84, 88, 90, 109], although it is not clear how acidification 
contributes to the process in vivo.  In chapter 2 and reference [109], we described the general 
features of the pH-triggered membrane insertion pathway of Bcl-xL, which consists of an initial 
membrane binding step followed by a refolding/insertion step (Fig. 4.1). 
 
FIGURE 4.1 pH-triggered membrane insertion pathway of Bcl-xL [109].  Figure displays 
the NMR structure of Bcl-xL (PDB 1LXL) in solution at neutral pH [66] and its pH-triggered 
membrane insertion pathway.  Helices α5 and α6, suggested to span the lipid bilayer, are colored 
in red.  Residues R102 and N175 were replaced to cysteine for specific labeling with Alexa488 
and NBD, respectively.  We suggest that both binding and insertion of the protein into the 
membrane are regulated by lipids.  
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There is emerging evidence emphasizing the role of the membrane itself in the action of the 
Bcl-2 family of proteins, MOMP and apoptosis [84, 88, 90, 100-111].  For example, cardiolipin, 
a phospholipid that is generally found in the mitochondrial membrane [8] and depleted during 
apoptosis [104], is required for the membrane interactions of Bid, Bax and Bcl-xL [83, 84, 103, 
115].  Our research group and others have shown that the membrane interactions of Bcl-xL can 
also be regulated by the mole fraction of phosphatidylglycerol [88, 90, 109].  Interestingly, 
cardiolipin and phosphatidylglycerol have a common chemical and physical property: the 
headgroup is negatively charged at pH values higher than 3.5 [112, 113].  It can then be 
hypothesized that Bcl-xL is regulated by a negatively charged membrane interface rather than 
distinct properties of cardiolipin or phosphatidylglycerol.  However, phosphatidylglycerol is also 
a precursor of cardiolipin during cardiolipin biosynthesis [8], and they might share some 
additional chemical or physical properties sensed by Bcl-2 proteins.  To distinguish between 
these alternatives, and determine the role of other lipids of biological relevance, it is necessary to 
characterize the role of membrane lipids on the membrane interactions of Bcl-2 proteins at the 
biophysical level. 
Here, we determine the effect of membrane lipids on the binding and insertion of Bcl-xL into 
the membrane using an array of fluorescence-based assays.  We tested the anionic lipids 
cardiolipin, phosphatidylglycerol, phosphatidylserine and phosphatidic acid; and the non-bilayer 
forming lipids phosphatidylethanolamine and lysophosphatidylcholine (Fig. 4.2).  These lipids 
are regularly found in different proportions in mitochondrial membranes [147],  some of them 
varying their mole fractions during apoptosis [104], or inducing mechanical changes in bilayers 
that are important for biological processes [148-150].  
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FIGURE 4.2 Structure and properties of membrane lipids used in this study.  Negatively 
charged lipids and zwitterionic lipids are on the left and right columns, respectively, with 
abbreviations in parenthesis. The net charge and relative abundance of each lipid are indicated 
below each structure [147, 151].  Changes in relative abundance during apoptosis are indicated 
for TOCL, POPA, POPC and LysoPC [104].  The abundance of the remaining lipids is either 
unknown (POPG and POPE) or unchanged (POPS).  LysoPC and POPE induce positive and 
negative curvature stress, respectively. 
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RESULTS 
Effect of anionic lipids on membrane binding 
The pH-triggered membrane insertion pathway of Bcl-xL consists of a membrane binding and 
a membrane insertion/refolding step [109].  We first tested the effect of lipids on the membrane 
binding step, starting with cardiolipin because of its suggested relevance in regulating MOMP 
and apoptosis [103, 115].  We monitored the membrane binding transition using the binding 
assay described in Chapter 2 and references [53, 109], where we follow the fluorescence changes 
associated with FRET between donor-labeled protein and acceptor-labeled LUV (we used 
Alexa488/Rhodamine as donor/acceptor pair).  In Fig. 4.3, we show a set of pH titrations for the 
binding of Bcl-xL to LUV composed of various mole fractions of 1,1,2,2-tetraoleoyl-cardiolipin 
(hereafter referred as cardiolipin or TOCL) in a POPC matrix.  For clarity, we normalized the 
FRET signal, where 100% represents the maximum change in intensity recorded in a set of 
experiments.  The results show that the binding isotherms are dependent on the mole fraction of 
TOCL.  We fitted the data to estimate the pKa and the cooperativity n of the process with Eq. 4.1 
[133].  This analysis indicates that the pKa of membrane binding of Bcl-xL shifts toward lower 
values upon reduction of the mole fraction of cardiolipin. 
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FIGURE 4.3 pH-dependence of binding of Bcl-xL to LUV composed of various mole 
fractions of cardiolipin (TOCL) and phosphatidylcholine (POPC).  Process was monitored 
by FRET between Bcl-xL/Alexa488 and LUV/Rhodamine-PE, where 100% represents the 
maximum signal change in a set of experiments.  pKa and n were determined by fitting the data 
with Eq. 4.1.  Results indicate that membrane binding of Bcl-xL depends on the mole fraction of 
cardiolipin. 
Previously, we reported that the membrane binding of Bcl-xL also depends on the mole 
fraction of phosphatidylglycerol [109] (See Chapter 2).  Both phosphatidylglycerol and 
cardiolipin have a negatively charged headgroup at pH values higher than 3.5 [112, 113], 
suggesting that Bcl-xL is responsive to a negatively charged membrane interface.  Alternatively, 
both lipids may share a common property that is sensed by Bcl-xL because phosphatidylglycerol 
is precursor in the biosynthesis of cardiolipin [8].  To distinguish between both possibilities, we 
performed pH titrations for the binding of Bcl-xL to LUV composed of other anionic lipids.  The 
results are summarized in Table 4.1, where we show the pKa and n values for the binding of Bcl-
xL to LUV whose lipid composition consists of various mole fractions of phosphatidylserine 
(POPS), phosphatidic acid (POPA), cardiolipin (TOCL) or phosphatidylglycerol (POPG) in a 
POPC matrix.  These results indicate that the pKa of membrane binding depends on the mole 
fraction of anionic lipids in all the cases.  Thus, it is likely that Bcl-xL senses the charge density 
at the membrane surface rather than a property unique to cardiolipin and phosphatidylglycerol. 
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Lipids mole fraction 
pKa 
(± 0.1) 
n 
(± 0.2) 
TOCL:POPC   3:2 6.0 1.7 
TOCL:POPC   1:2 5.7 1.6 
TOCL:POPC   1:4 5.3 1.6 
TOCL:POPC   1:6 5.0 1.7 
POPG:POPC   3:1 6.0 1.6 
POPG:POPC   1:3 5.0 1.5 
POPS:POPC   3:1 5.9 1.4 
POPS:POPC   1:1 5.7 1.5 
POPS:POPC   1:3 5.1 1.5 
POPA:POPC   3:1 5.9 1.3 
POPA:POPC   1:1 5.6 1.4 
POPA:POPC   1:3 5.0 1.4 
TABLE 4.1 pH-dependent binding parameters of Bcl-xL to LUV of various lipid 
compositions.  pKa and cooperativity n was estimated fitting the FRET binding data with Eq. 
4.1.  Lipid compositions are expressed as the mole fractions. 
To verify that the membrane binding of Bcl-xL depends on the charge density at the membrane 
interface, we tested the effect of ionic strength on the membrane binding of Bcl-xL.  The theory 
of the electrical double layer predicts that counterions are attracted to a charged surface and 
modulate the effective electrostatic potential [152].  Fig. 4.4A shows that the pKa of binding is 
indeed modulated by the ionic strength, as it shifts toward lower values upon addition of NaCl.  
Because membrane is promoted by increasing mole fractions of anionic lipids and hindered by 
increasing ionic strength, we conclude that electrostatic interactions modulate the membrane 
interactions of Bcl-xL.   
In order to quantitatively characterize these interactions, we calculated the electrostatic surface 
potential ( 0 ) using the Gouy-Chapman equation (Eqs. 4.3 and 4.4), which describes 0  as 
function of the charge per area of lipid and ionic strength [152].  Despite being a theoretical 
approximation, this equation predicts experimental measurements with remarkably agreement 
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[152-154].  We plotted the pKa of membrane binding modulated by both methods as function of 
0  (Fig. 4.4B), and found that both variables are linearly correlated.  We applied linear fitting 
with Eq. 4.5 and free fitting parameters for the binding of Bcl-xL to the different membrane 
systems (only that of cardiolipin-containing LUV is shown in the figure).  According this 
equation the slope (0.019 mV
-1
) describes the dependence of the apparent pK value (pKa) on the 
membrane surface potential, while the intercept (3.8) corresponds to the intrinsic pK value (pKi).  
The fact that the rest of the data fall within the same linear fit, regardless of the mode of 
modulation of the membrane surface potential, demonstrates that the partitioning of Bcl-xL to 
the membrane depends on the electrostatic potential at the membrane interface.   
 
FIGURE 4.4 Regulation of membrane binding of Bcl-xL by membrane surface potential.  
A) pH-titrations for membrane binding of Bcl-xL in the presence of additional NaCl.  pK and 
cooperativity n were determined by fitting the data to Eq 4.1.  B) pKa of membrane binding of 
Bcl-xL as function of the membrane surface potential ( 0 ) calculated with Eqs. 4.3 and 4.4.  
There is a linear correlation between the pKa and 0 , regardless of its mode of manipulation. 
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To complete the thermodynamic characterization, we converted the pKa values into apparent 
free energies of protonation (ΔGa) using Eq. 4.2.  The resulting ΔGa values were plotted against 
the corresponding membrane surface potential and fitted with Eq. 4.6 with free fitting parameters 
(Fig. 4.5, black linear fit).  Remarkably, the free fitting of the experimental values overlaps with 
a theoretical fit (red fit) whose slope is fixed in 0.023 kcal mol
-1
mV
-1
.  According Eq. 4.6, this 
slope (Faraday constant) corresponds to the ideal modulation of free energy of protonation by the 
membrane surface potential.  Thus, this analysis not only confirms that membrane binding of 
Bcl-xL depends on the membrane surface potential, but also suggests that it is the main 
regulatory component for initial membrane association. 
 
FIGURE 4.5 Thermodynamics of membrane binding of Bcl-xL to LUV.  pKa values were 
converted into free energies of protonation with Eq. 4.2 and plotted against the membrane 
surface potential.  While the experimental fit has free fitting parameters, the theoretical fit has a 
fixed slope of 0.023 kcal mol
-1
mV
-1
.  According to Eq. 4.6, this slope describes the ideal 
modulation of free energy by the membrane surface potential. 
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Effect of anionic lipids on membrane insertion/refolding 
Next, we tested the effect of lipids on the membrane insertion/refolding step, where helices α5 
and α6 are suggested to insert as a hairpin into the lipid bilayer [85, 109].  To monitor the 
insertion of helix α6, we performed site-directed labeling at residue 175 with the environment 
sensitive probe NBD.  In Chapter 2 and reference [109], we showed that membrane insertion of 
th labeled helix results in blue shift and increase of fluorescence intensity of NBD.  In Fig. 4.6A, 
we show representative pH-titrations for the membrane insertion of Bcl-xL into LUV composed 
of various mole fractions of cardiolipin.  The change in signal, normalized to the maximum 
change in NBD intensity in a set of experiments, demonstrates that Bcl-xL inserts into 
cardiolipin-containing LUV.  However, as in the case of the membrane binding experiments 
(Fig.4.2), the membrane insertion depends on the mole fraction of cardiolipin.  The fitting 
analysis with Eq. 4.1 (solid lines) indicates a shift of pKa toward lower values as the mole 
fraction of cardiolipin is decreased.  These fitting parameters are comparable to those obtained in 
the binding experiments under the same conditions (Fig 4.2), suggesting that initial binding and 
membrane insertion cannot be distinguished by modulating the mole fraction of cardiolipin. 
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FIGURE 4.6 Effect of anionic lipids on the insertion/refolding of helices α5-α6 into the 
bilayer monitored through changes in the fluorescence intensity of NBD-labeled Bcl-xL.  A) 
pH-titrations for the insertion/refolding of Bcl-xL into LUV of various mole fractions of 
cardiolipin (TOCL) and phosphatidylcholine (POPC).  pKa and cooperativity n were determined 
by fitting the data with Eq. 4.1.  B) pKa of membrane insertion/refolding of Bcl-xL plotted as a 
function of the membrane surface potential ( 0 ).  There are linear correlations between the pKa 
values and the membrane surface potential, but the slopes are different for each lipid. 
On the next step, we characterized the insertion/refolding of Bcl-xL into LUV composed of 
other anionic lipids (POPG, POPS and POPA).  Table 4.2 summarizes the parameters obtained 
by fitting each of the pH titrations with Eq. 4.1, where it is clear that the pKa of membrane 
insertion was affected by the lipid composition in different degrees.  In order to better visualize 
these effects, we plotted the pKa values as function of the membrane surface potential (Figure 
4.5B).  The data show that the correlation between pKa and membrane surface potential is 
different in all the lipid systems (note the different slopes).  This suggests that the membrane 
insertion/refolding of Bcl-xL is not regulated by the membrane surface potential alone, but there 
are additional properties playing a role.  The further analysis of the data with Eq. 4.5 supports the 
possibility of differential regulation at the level of the membrane insertion/refolding.  While the 
slopes for the TOCL and POPA lipid systems (0.020 mV
-1
 and 0.017 mV
-1
, respectively) are 
similar to the slope of the initial binding step (0.019 mV
-1
), the slopes for the POPG and POPS 
systems are clearly different (0.005 mV
-1 
and 0.007 mV
-1
, respectively).  This shows that the pH 
required for membrane insertion of Bcl-xL into membranes made of TOCL or POPA is the same 
pH required for initial binding.  However, if the membrane contains POPG and POPS, Bcl-xL 
requires a specific pH regardless of that required for membrane binding.   
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Lipids mole fraction 
pKa 
(± 0.1) 
n 
(± 0.2) 
TOCL:POPC   3:2 6.1 1.0 
TOCL:POPC   1:2 5.8 1.0 
TOCL:POPC   1:4 5.6 1.1 
TOCL:POPC   1:6 5.2 1.3 
POPG:POPC   3:1 5.5 1.1 
POPG:POPC   1:1 5.5 1.1 
POPG:POPC   1:2 5.4 1.0 
POPG:POPC   1:3 5.2 1.4 
POPS:POPC   3:1 5.6 1.1 
POPS:POPC   1:1 5.5 1.2 
POPS:POPC   1:3 5.2 1.1 
POPA:POPC   3:1 6.2 1.3 
POPA:POPC   1:1 5.9 1.0 
POPA:POPC   1:3 5.2 1.0 
TABLE 4.2 Parameters of pH titrations of insertion/refolding of Bcl-xL into LUV of 
various lipid compositions.  pKa and cooperativity n was estimated fitting the data of Fig. 4.6 
with Eq. 4.1.  Lipid compositions are expressed as mole fractions. 
Kinetic regulation of the membrane insertion/refolding  
To test if anionic lipids also modulate the rate of membrane insertion/refolding in a lipid-
specific manner, we measured the time course of helix α6 insertion using NBD fluorescence.  
We used lipid compositions with low membrane surface potential (-67mV) because the insertion 
of Bcl-xL reached completion within the dead time (~5 seconds) in LUV of high anionic content.  
Also, we used pH 4.5 to ensure formation of the membrane-inserted state (Fig. 4.6 shows that at 
pH 4.5, the formation of the transmembrane state is almost complete).  Fig. 4.7 displays the time 
course of membrane insertion/refolding of Bcl-xL into LUV of the various lipid compositions.  
The rate of insertion appears to be similar in all the cases but when POPS is used.  This lipid is 
reported to have a pKa of protonation of about 5, which complicates the analysis because the 
effective charge is <1.  We fitted the data to an empirical exponential association (see methods) 
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of two components (k1 and k2) and one fast step (k0 = 0).  Although the rate (ki) and time 
constants (τi) show differences (Table 4.3), these are not as dramatic as those observed when 
varying the mole fraction of POPE (see below).  Since τα varies less than 2 folds among the 
different lipid systems, we conclude that the anionic lipids do not modulate the rate of 
insertion/refolding of Bcl-xL in a lipid-specific manner.  
 
FIGURE 4.7 Effect of different anionic lipids in the kinetics of insertion/refolding of Bcl-xL 
into LUV.  The rate of insertion into LUV of low anionic mole fraction was followed by changes 
in intensity of the environment-sensitive dye NBD slectively attached to a residue in helix α6 as 
described in [109].  We chose lipid compositions with anionic lipids of different headgroups but 
similar membrane surface potential (-67 mV).  Solid black lines are fitting curves (see text and 
methods for details).  
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Lipid composition A0 A1 k1, s
-1
 A2 k2, s
-1
 τα,, s 
Anionic lipids 
POPG:POPC 1:3 0.37 0.35 1.4 x 10
-2
 0.28 1.9 x 10
-3
 1.7 x 10
2
 
TOCL:POPC 1:6 0.51 0.22 0.8 x 10
-2
 0.27 1.1 x 10
-3
 2.7 x 10
2
 
POPS:POPC 1:3 0.33 0.29 1.5 x 10
-2
 0.38 1.0 x 10
-3
 4.0 x 10
2
 
POPA:POPC 1:3 0.44 0.18 2.1 x 10
-2
 0.38 3.3 x 10
-3
 1.3 x 10
2
 
Membrane curvature 
POPE:POPC:POPG  
1:2:1 
0.36 0.41 1.7 x 10
-2
 0.23 2.9 x 10
-3
 1.0 x 10
2
 
 
POPE:POPG 3:1 0.51 0.35 5.6 x 10
-2
 0.14 14.3 x 10
-3
 1.6 x 10
1
 
LysoPC:POPC:POPG  
1:2:1 
0.33 0.21 1.2 x 10
-2
 0.46 0.9 x 10
-3
 5.3 x 10
2
 
Binding  
POPG:POPC 1:3 0.34 0.42 1.2 x 10
-2
 0.24 1.2 x 10
-3
 2.4 x 10
2
 
POPG:POPE 1:3 0.94 0.06 14.8 x 10
-2
 0 - < 1 
TABLE 4.3 Quantitative analysis of the kinetics of insertion of Bcl-xL into LUV of various 
lipid compositions.  The kinetic data was fitted to an empirical exponential association (see 
methods) of two components (k1 and k2) and one fast step (k0 = 0).  
Finally, we tested the effect of the zwitterionic and non-bilayer forming lipid 
phosphatidylethanolamine (POPE) on the membrane insertion/refolding of Bcl-xL.  This  lipid, 
which induces negative curvature stress in biological membranes due to its intrinsic curvature [6, 
150], has been reported to act as chaperone for membrane protein folding [148, 149].  In this 
experiment, we kept a constant mole fraction of POPG as the anionic lipid (as required for 
membrane binding) and increased the mole fraction of POPE in replacement of POPC.  The 
results (Fig. 4.8) indicate that the rate of insertion becomes faster as the POPE mole fraction 
increases.  This is consistent with POPE chaperoning the refolding of Bcl-xL within the 
membrane.  To determine if POPE effect relates to its intrinsic negative curvature, we replaced a 
fraction of POPC by lysophosphatidylcholine (LysoPC).  In contrast to the case of POPE, 
LysoPC (dark yellow) slowed down the membrane insertion of Bcl-xL (rate constants presented 
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in Table 4.3).  Our results suggest that membrane curvature modulates the kinetics of membrane 
insertion/refolding of Bcl-xL.  
 
FIGURE 4.8 Effect of POPE and LysoPC in the insertion of Bcl-xL into the lipid bilayer at 
pH 4.5.  Time-course of insertion of Bcl-xL into LUV composed of 25 mole percent of POPG 
and various mole fractions of POPC and POPE or LysoPC.  POPE and LysoPC cause opposite 
effects in the insertion kinetics.  
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DISCUSSION   
In this chapter, we have characterized the effect of various lipids on the membrane interactions 
of Bcl-xL, an anti-apoptotic member of the Bcl-2 family of proteins.  We used a set of 
fluorescence-based assays to determine how lipids, commonly found in the mitochondrion, 
modulate the pH-dependence of initial membrane association and refolding of Bcl-xL within the 
lipid bilayer.  Our results suggest that lipids can regulate the membrane interactions of Bcl-xL in 
multiple ways.  The initial membrane association of Bcl-xL is modulated by the membrane 
surface potential created by any lipid with a negatively-charged headgroup.  In contrast to a 
general electrostatic mechanism, membrane lipids affect the membrane insertion/refolding of 
Bcl-xL in a lipid-specific manner.  In addition, the rate of insertion into the membrane appears to 
be modulated by the curvature stress induced by non-bilayer forming lipids. 
Cardiolipin is suggested to be crucial for the action of the Bcl-2 family of proteins, and 
multiple biophysical and biochemical studies use this lipid as part of the experimental system to 
ensure membrane interactions of these proteins [79, 83, 84, 155-157].  However, cardiolipin may 
be required because of its double negatively charged headgroup or because of some unique 
property that is important for apoptosis regulation.  While we do not rule out that cardiolipin may 
have unique properties that are important for proper function of the Bcl-2 proteins, our results 
show that cardiolipin regulates membrane partitioning of Bcl-xL because of its anionic nature 
(Figs. 4.3-4.5).  Indeed, we show that Bcl-xL is responsive to the charge density at the membrane 
interface, as modulation of the membrane surface potential by changing the mole fractions of 
other anionic lipids or ionic strength results in a shift on the pKa of membrane binding.  Our 
study is in agreement with a previous study that suggested that Bcl-xL association with the 
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membrane was governed by an electrostatic component [88], although the lipid composition was 
not explored in that study.  This electrostatic component and the effect on the pKa of membrane 
partitioning imply that the role of pH in the membrane partitioning of Bcl-xL depends on the 
membrane properties, i.e. Bcl-xL would partition into the membrane at physiological pH if the 
interface is negative enough. 
For the membrane insertion/refolding of Bcl-xL, our results suggest a different mechanism, 
where the process appears to be regulated in a lipid specific-manner (Fig. 4.6).  While the 
regulation by cardiolipin and POPA is indistinguishable from that observed in the binding step of 
Bcl-xL, the dependence of the pKa on the membrane surface potential is lost in the case of 
POPG and POPS.  There are three possible explanations for this result: 1) Bcl-xL is trapped in 
some intermediate state in the presence of POPG or POPS, with the constraint being released 
upon further acidification; 2) Bcl-xL follows an alternative insertion pathway depending on the 
lipid composition; or 3) the final transmembrane state has a different topology that is dependent 
on the lipid composition.  Since high resolution structures of Bcl-xL in the membrane are not 
available, distinguishing between the three alternatives is challenging and requires further 
structural and functional research. Nonetheless, lipids regulate the final refolding within the 
membrane in a lipid-specific fashion.  It is possible that the size of the headgroup is involved in 
this regulation.  Cardiolipin and POPA have smaller headgroups because, in contrast to POPG 
and POPS, they do not have a functional group attached to the phosphate group (Fig. 4.2).  While 
the pH-dependence on the surface potential is similar for cardiolipin and POPA, at both 
membrane binding and insertion events, the membrane insertion into LUV containing POPG or 
POPS appears to lose pH-dependence on the surface potential.  
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Interestingly, our experiments with non-bilayer forming lipids show regulation of the 
membrane interactions of Bcl-xL at the kinetic level (Fig. 4.8).  POPE and LysoPC caused 
opposite effects on the rate of membrane insertion of Bcl-xL without affecting the total 
magnitude of the change, suggesting that properties at the equilibrium remain the same.  While 
POPE increased the rate of the insertion, LysoPC decreased it.  This result correlates with the 
properties of POPE and LysoPC, which are lipids with opposite intrinsic curvature [150].  Thus, 
it is possible that the presence of curvature stress at the surface of the membrane controls an 
energetic barrier that Bcl-xL has to overcome in order adopt its final topology.  Previous studies 
have shown that POPE can act as a chaperone to ensure proper folding of membrane proteins 
[149, 158, 159]. 
Previous studies have shown that the Bcl-2 family of proteins plays a regulatory role in 
apoptosis because they control the permeabilization of the mitochondrial outer membrane, a 
process that irreversibly leads to cell death [47, 71, 73].  The Embedded Together Model of 
apoptotic regulation suggests that MOMP can be modulated at four levels: 1) protein-protein 
interactions in the cytosol, 2) partition of Bcl-2 proteins into the mitochondrial outer membrane, 
3) protein-protein interactions at the mitochondrial membrane, and 4) pore formation leading to 
cell death [82].  Although there is much debate on the exact mechanisms of interaction and 
regulation of Bcl-2 proteins [75, 76], it is clear that the membrane environment is playing a 
central role.  However, the few studies that address the role of the mitochondrial membrane in 
apoptosis focus mainly in the levels 3 and 4, i.e. protein-protein interactions leading to or 
preventing cell death (e.g. membrane modulating the dissociation constants [84]).  Our results 
provide evidence that the partitioning and refolding of Bcl-xL into the membrane can also be 
regulated by the properties of the lipid bilayer.  Interestingly, recent research has shown that the 
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lipid composition of the mitochondrial membrane varies before, during and after apoptosis [104].  
Thus, regulating the lipid composition may be a mode of controlling the action of Bcl-2 proteins 
in the cell.  Furthermore, our study provides basis for subsequent studies of bilayer modulated 
protein-protein interactions in apoptotic regulation. 
Taken together our results indicate that lipids can modulate the membrane interactions of Bcl-
xL in multiple ways, providing an additional regulatory mechanism that ensures proper control 
of a complex cascade of apoptotic reactions leading to cell death or survival.  It will be of 
interest to test if this holds true for other members of the Bcl-2 family, or if pro- and anti-
apoptotic proteins are regulated by the membrane in a different fashion.  The latter is also 
extensive to other proteins that undergo spontaneous membrane insertion (e.g. bacterial toxins, 
antimicrobial peptides), either in a pH-dependent fashion or not, to determine if the lipid 
composition is a universal mode of regulation for the action of proteins in biological membranes. 
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MATERIALS AND METHODS 
Materials: Palmitoyl-oleoyl-phosphatidylcholine (POPC), palmitoyl-oleoyl-
phosphatidylglycerol (POPG), palmitoyl-oleoyl-phosphatidylserine (POPS), palmitoyl-oleoyl-
phosphatidic acid (POPA), palmitoyl-oleoyl-phosphatidylethanolamine (POPE), 1,1,2,2-
tetraoleoyl-cardiolipin (TOCL), cholesterol (Cho), Lyso-phosphatidylcholine (LysoPC) and 
Rhodamine-PE were purchased from Avanti Polar Lipids (Alabaster, AL).  IANBD-ester and 
AlexaFluor488-maleimide were obtained from Invitrogen (Carlsbad, CA).  Bcl-xL (lacking the 
C-terminal TM helix and carrying an N-terminal His-tag for purification) mutants C151S/R102C 
and C151S/N175C were expressed and purified as previously described [109].  Labeling with 
fluorescent dyes was performed using a standard procedure for thiol-reactive derivatives [109, 
129] and the unreacted dye was removed by gel filtration chromatography. 
LUV preparation: Large unilamellar vesicles containing molar mixtures of POPG:POPC, 
TOCL:POPC, POPS:POPC, POPA:POPC, POPG:POPE, POPG:POPC:Cho, and 
POPG:POPC:LysoPC of 0.1 µm diameter were prepared by extrusion as previously described 
[130, 131].  For the FRET experiments, 2% of Rhodamine-PE was incorporated to the lipid 
mixture. 
Fluorescence measurements and analysis: Steady-state fluorescence emission of Alexa488 and 
NBD labeled protein was measured using a SPEX Fluorolog FL3-22 steady-state fluorescence 
spectrometer (Jobin Yvon, Edison, NJ) equipped with double-grating excitation and emission 
monochromators.  The measurements were made in a 2x10 mm cuvette oriented perpendicular to 
the excitation beam and maintained at 25ºC using a Peltier device from Quantum Northwest 
(Spokane, WA) in 1 nm steps.  The excitation and emission wavelengths for Alexa488 
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measurements were 455 and 470-700 nm, respectively, using slits of 2 nm on both 
monochromators.  For NBD measurements, the emission spectra was collected from 490 to 700 
nm, and the excitation wavelength was 470 nm, using slits of 5 nm on both monochromators.  
For each spectrum, we averaged 5 scans after incubating the samples at least 30 min for 
equilibration.  The samples normally contained 0.3μM protein in 50mM phosphate buffer at pH 
8.0, unless indicated, and 0.5mM of lipid.  The acidification was achieved by the addition of 
small aliquots of acetic/acetate buffer.  The fractions (F) of membrane-bound or membrane-
inserted states were calculated by normalization of the data to the maximum signal change.  The 
pH-dependencies of these fractions were fitted to the following equation [133]: 
)pKapH(n
F


101
1
       (Eq. 4.1) 
where pKa is a negative logarithm of the dissociation constant, and n is the Hill coefficient. 
The apparent free energy of protonation (ΔGa) was calculated by rearranging the Gibbs 
equation: 
)pKa(RT.Ga 32        (Eq. 4.2) 
where R and T are the gas constant and absolute temperature, respectively, and the pKa is 
obtained with Eq. 4.1. 
Membrane surface potential calculations: The calculation of the membrane surface potential 
was performed using the Gouy-Chapman theory [152].  This model describes the electric 
potential along the axial plane of the membrane, where the potential at the membrane surface Ψ0 
depends on the surface charge density σ and the concentration of counterions according to: 
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κ
B
 is the Boltzmann constant (1.38 x 10
-23
 J/K), T is the absolute temperature, z is the valence 
of the counterion (+1 in our case), e is the elementary electric charge (-1.602 x 10
-19
 C), N is the 
Avogadro number (6.022 x 10
23
 mol
-1
), ε
0 
is the permittivity in vacuum (8.854 x 10
-12
 C
2
m
-1
/J), ε
r 
is the dielectric constant of water (78.3).  c is the concentracion of counterions expressed in 
mol/m
3
, while σ is the surface charge density expressed in C/m
2
. 
The surface charge density was calculated according the following equation: 
NLNLALAL
ALAL
AA
ez





 ,       (Eq. 4.4) 
where z
AL
 is the net charge of the anionic lipid, χ
AL
 and χ
NL
 are the mole fractions of the anionic 
and neutral lipid, respectively, and A
AL
 and A
NL
 are the area per lipid of the anionic and neutral 
lipid, respectively, in units of m
2
.  For the net charges, we used values of 0 for POPC, -1e for 
POPG, POPS and POPA, and -2e for TOCL, and further assume that they were constant over the 
range of pH tested in this study (pH4-8).  For the areas per lipid, we used the cross-sectional 
areas described in the literature for the crystalline phase assuming a cylindrical shape: 64 Å
2
 for 
POPC [160], 66 Å
2
 for POPG [161], 63 Å
2
 for POPS [13], and 130 Å
2
 for TOCL [162].  We also 
used a value of 68 Å
2
 for POPA, which was reported by MD simulations [163] (experimental 
values range from 42 to 89 Å
2
 [164]).  We further assume that the area per lipid is not affected 
by the mixing of different lipids, the presence of the protein, or the concentration of ions. 
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Finally, the correlation between the free energy of protonation and the membrane surface 
potential can be described by the equation suggested Fernandez and Fromherz [125]: 
0
32

RT.
F
pKpK ia         (Eq. 4.5) 
where pKa and pKi are the observed apparent pK and intrinsic pK, respectively, F is the 
Faraday constant, R is the gas constant and T the absolute temperature. 
Eq. 4.5 can be further combined with Eq. 4.2 to describe the process in terms of free energy: 
0FGG ia          (Eq. 4.6) 
where ΔGa and ΔGi are apparent and intrinsic free energies of protonation, respectively, and F 
is the faraday constant (0.023kcal mol
-1
mV
-1
).  Eq. 4.6 describes the ideal modulation of free 
energy by the membrane surface potential. 
Kinetic measurements and analysis:  Time course of membrane insertion were performed 
using NBD-labeled Bcl-xL.  The emission wavelength was fixed at 525 nm and the intensity was 
recorded in steps of 1 second.  The intensity signal (I) was fitted to an empirical three-component 
exponential association equation: 
)e(A)e(AAI
tktk 21 11 210

      (Eq. 4.7) 
where Ai are the amplitudes of the corresponding kinetic component with apparent rates of ki 
(A0 corresponds to the amplitude of a fast component with k0=0).  The sum of all amplitudes 
corresponds to the total fraction of inserted state. 
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CHAPTER 5  CONCLUSIONS AND FUTURE DIRECTIONS 
In this dissertation, we have addressed three different aspects on the pH-triggered membrane 
insertion of proteins.  In chapter 2, we established that there are multiple mechanisms of pH-
triggered membrane insertion of proteins.  We determine the pH-induced membrane insertion 
pathway of the anti-apoptotic regulator Bcl-xL and compare it to that of the structurally similar 
diphtheria toxin T domain.  We show differences in their membrane insertion pathways that may 
be relevant for their physiological action.  In chapter 3, we determined the role of histidine 
protonation upon acidification in the membrane insertion and folding of proteins.  We 
specifically investigate the role of a cluster of histidines located at the C-terminal region of the 
diphtheria toxin T domain.  We show that H322 is critical for proper folding and activity of the 
N-terminal helices of the T domain in the membrane.  Finally, in chapter 4, we studied the role 
of the physicochemical properties of the membrane itself in regulating the pH-triggered 
membrane interactions proteins.  We found that the charge density at the membrane interface is 
critical for the initial binding of the Bcl-xL, while additional properties (e.g. membrane curvature 
stress) regulate the transmembrane insertion. 
BCL-XL VERSUS T DOMAIN 
The structural similarities between Bcl-xL and the diphtheria toxin T domain had led to 
hypothesize that they shared common features in their membrane interactions [64, 66].  Here, we 
tested the validity of this assumption by directly comparing the membrane insertion pathways of 
both proteins.  For a more accurate comparison, we truncated the TM helix of Bcl-xL, which is 
proposed to anchor the protein to the membrane [85, 86] in a similar fashion as the R domain of 
the diphtheria toxin.  Then, we showed that acidification does not cause a noticeable structural 
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change in Bcl-xL using measurements of secondary structure and thermal unfolding with CD 
spectroscopy (Figs. 2.4 and 2.5).  In diphtheria toxin T domain, however, mild acidification 
causes the conversion of a membrane-incompetent into a membrane-competent state.  Then, we 
studied the membrane association of Bcl-xL using a FRET assay, and we found that this 
association depends on the mole fraction of anionic lipids in the membrane (Figs. 2.6-2.8).  This 
is different from the case of the T domain, which shows no dependence on the lipid composition 
in the initial membrane binding.  Lastly, we compared the transmembrane insertion of Bcl-xL 
with that of the T domain (Figs. 2.9-2.11), where no major differences where observed.  In this 
case, the membrane interactions of the anti-apoptotic regulator were already regulated by lipids 
at the binding step, while those of the toxin were regulated at the final step. 
The likely reason for the differences observed in the insertion pathways of both proteins is that 
the membrane-competent states are formed in different places: in solution for the T domain and 
in the membrane interface for Bcl-xL.  This has implications in the regulation of membrane 
interactions of both proteins because the membrane partitioning of Bcl-xL can be modulated by 
the lipid composition, while that of the T domain is not.  Physiologically, the lack of regulation 
by lipids is important for the T domain because it ensures robust membrane association 
regardless of the lipid composition.  For Bcl-xL, however, regulation by lipids acts as rheostat 
for membrane association because insufficient or excessive association with the membrane 
disrupts the life/death balance. 
The differential regulation of the process for both proteins also suggests a distinct pH-trigger.  
Since the formation of the membrane-competent form of the T domain is triggered in solution at 
pH values 6-6.5, histidine protonation plays an important role.  Several lines of evidence indicate 
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that protonation of histidines at the N-terminal cluster is required for proper conformational 
switching of the T domain in solution and membrane interactions.  In contrast, the formation of 
the membrane-competent form of Bcl-xL occurs at the membrane interface, suggesting that 
histidine protonation is not necessarily the trigger of the conformational changes.  It is suggested 
that the membrane interface alters the pKa of protonation of amino acid lateral chains.  Thus, 
protonation of acidic residues, rather than histidines, may play a major role for the membrane 
interactions of Bcl-xL.  Although it is a challenge to determine the specific residues involved in 
the process (Bcl-xL possesses 31 acidic residues), identifying these residues will provide further 
understanding in the mechanism of pH-triggered membrane insertion of this protein.  
The comparison between the T domain and Bcl-xL was initially useful in apoptosis research 
because it shed light into the functional role of the Bcl-2 family of proteins.  However, as 
described here and in reference [109] (published outcome of chapter 2 of this dissertation), both 
proteins follow different membrane insertion mechanisms.  We suggest that the knowledge built 
in the membrane interactions of the T domain is not applicable to understand the membrane 
interactions of Bcl-xL.  Bcl-xL and T domain play different roles in the membrane as well:  
while the T domain forms a channel to allow the passage of a polypeptide during bacterial 
infection, Bcl-xL prevents the permeabilization of the membrane to polypeptides.  Thus, the T 
domain and Bcl-xL should not be expected to interact with the membrane in a similar fashion.  
However, we do not rule out that other members of the Bcl-2 family of proteins share 
mechanistic similarities with the T domain.  Future studies should address the case of Bcl-2 
proteins whose function is the formation of pores, such as Bak and Bax. 
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HISTIDINES AND FOLDING OF T DOMAIN IN THE MEMBRANE 
In chapter 2, we determined the role of H322 in the membrane folding of the T domain.  This 
residue is part of group of three histidines that are clustered at the top of helices TH8-TH9, 
which is the membrane insertion unit of the diphtheria toxin T domain.  Previously, it was shown 
that the triple replacement of these histidines to glutamine or arginine caused loss of 
translocation activity and inability to reach the open-channel state [68].  However, the membrane 
insertion of TH8-TH9 was not affected, which suggested uncoupling of the membrane insertion 
of these helices with folding into an open-channel state.  Here, we determined that the 
replacement of H322 alone is sufficient to cause those effects; however, the simultaneous 
mutation of the three histidines appears to further affect the activity of the T domain (Table 3.1).  
We also showed that the mutation of H322 alone does not cause misfolding in solution, but leads 
to the formation of non-productive intermediate states in the membrane, which then misfold and 
possibly aggregate (Figs. 3.2-35).  Similarly, the simultaneous replacement of this and the other 
histidines enhances the effect of H322 on the membrane folding of the T domain. 
Previous research showed that another group of histidines, clustered around the N-terminal 
helices of the T domain, are important for triggering the initial conformational changes in 
solution [50, 52].  In the case of the N-terminal histidines, the replacement to arginine and to 
glutamine cause opposite effects, i.e. the presence of a positive charge triggers the 
conformational switching in solution and the absence of a charge delays the conformational 
change.  Thus, protonation of the N-terminal histidines would be the signal for the T domain to 
execute its membrane action.  A similar mechanism has been suggested for histidine residues in 
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other proteins, such as the protective antigen of the anthrax toxin [165] and the influenza 
hemagglutinin [166, 167].   
In the case of the C-terminal histidines, the conformational changes do not appear to respond 
to mere protonation because the mutation to either lysine or glutamine causes indistinguishable 
effects.  It is possible that the mechanism by which the C-terminal histidines affect T domain’s 
function and folding is their ability to protonate/deprotonate rather than the protonation itself.  
The membrane interface has been shown to modulate the apparent pKa of protonation of 
titratable peptides [125, 168, 169].  If this is the case, H322 may undergo multiple events of 
protonation and deprotonation as the T domain refolds into the membrane, where the membrane 
interface modulates the pKa.  It is challenging to test this hypothesis experimentally; however, 
future studies may take advantage of computational tools to visualize whether this may be the 
case.   
The replacement of the C-terminal histidines may prevent the proper membrane insertion of 
the TH5 helix, which is suggested to become transmembrane along with TH8 and TH9 in the 
open-channel state [51].  The mutation of the C-terminal histidines causes lack of blue-shifted 
tryptophan spectra and loss of channel activity.  Since tryptophan fluorescence is affected by the 
polarity of the environment [139], it is possible that one or both tryptophans of the T domain 
(W206 and W281) do not penetrate the lipid bilayer.  W281 is located in the middle of TH5, 
suggesting that it is possible that TH5 is unable to properly fold into the membrane in the case of 
the mutants.  This would explain not only the lack of blue-shift of the tryptophan emission 
spectrum, but also the loss of channel formation activity because membrane insertion of TH5 is 
suggested to be required for such activity [51].  Initial studies to test this hypothesis, where 
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W281 is the only fluorescence internal probe, confirm that replacement of the C-terminal 
histidines impedes the membrane insertion of TH5 (unpublished results from Dr. Ghakat and Dr. 
Ladokhin).  Similarly, extended molecular dynamic simulations of the T domain in the 
membrane will contribute to better visualize the molecular link between the C-terminal histidines 
and TH5 penetration.  
LIPID REGULATION OF MEMBRANE INTERACTIONS OF BCL-XL 
In chapter 3, we have characterized the effect of the membrane lipid composition on the 
membrane interactions of Bcl-xL.  First, we studied the effect of membrane lipids on the initial 
membrane binding of Bcl-xL by using a FRET assay (Figs. 4.3-4.5 and Table 4.1).  Our data 
showed that the pKa of membrane binding can be modulated by varying the mole fraction of 
anionic lipids, regardless of the type of lipid.  This suggested that membrane association of Bcl-
xL responded to negatively charged membranes rather than to specific lipids.  Varying the ionic 
strength of the solution also affected the pH-dependence of membrane binding of Bcl-xL, 
supporting the idea of the charge density at the membrane interface playing a role in the action of 
Bcl-xL.  There was a linear correlation between the pKas of membrane binding and the 
membrane surface potential, regardless of the lipid system or the ionic strength conditions.  
Thus, we concluded that the initial membrane association of Bcl-xL depends on the charge 
density of the membrane interface. 
Previous research had suggested that the mitochondrial lipid cardiolipin was required for the 
membrane association of Bid, Bax and Bcl-xL [83, 84, 103, 115].  However, here we show that 
any lipid with a negatively charged headgroup can replace cardiolipin for the initial membrane 
association of Bcl-xL.  We do not rule out that cardiolipin may play unique roles in modulating 
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the membrane refolding of Bcl-xL once in the lipid bilayer.  Similarly, cardiolipin may play 
additional roles that can be important for the function of Bcl-xL or other Bcl-2 family proteins in 
vivo.  However, for the purposes of in vitro studies, it appears that Bcl-xL can be tethered to the 
membrane by either increasing the mole fraction of anionic lipids or decreasing the ionic 
strength. 
Second, we studied the effects of different lipids on the transmembrane insertion of Bcl-xL.  In 
contrast to the binding event, we found that lipids modulate the transmembrane insertion and 
refolding of Bcl-xL in the membrane in a lipid-specific manner.  The replacement of cardiolipin 
with other anionic lipids did not cause shifts in the pKa in the same degree as cardiolipin does.  
Since the membrane interactions of Bcl-xL were already regulated at the membrane association 
step, this lipid-specific regulation suggests that there are additional physicochemical properties 
of the lipids that modulate Bcl-xL refolding.  One possibility is the size of the lipid headgroup, 
which would affect the size of the interfacial region and therefore the proximity of Bcl-xL to the 
hydrocarbon core once in the bilayer.  In the case of POPA and cardiolipin, the dependence of 
the pKa on the membrane surface potential is similar in both the binding and insertion events 
(similar slopes in Figs. 4.4 and 4.6).  These lipids also have a smaller headgroup because of the 
lack of a functional group attached to the phosphate group (Fig. 4.2).  In the case of POPG and 
POPS, where the lipid headgroup is larger, the dependence of pKa on the membrane surface 
potential (slopes in Figs. 4.4 and 4.6) is greatly reduced in the insertion event, suggesting that 
these lipids constrain the membrane insertion of Bcl-xL. 
We also observed modulation of the membrane insertion of Bcl-xL by non-bilayer forming 
lipids.  In this case, POPE and LysoPC affected the rate of membrane insertion in opposite ways 
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(Fig. 4.8).  POPE and LysoPC are lipids that induce mechanical stress in lipid bilayers because 
of their intrinsic curvature (negative and positive curvature, respectively).  It is possible that 
mechanical properties of the membrane are important for modulating the refolding of Bcl-xL 
within the membrane.  Thus, our results are in agreement with previous reports claiming that 
POPE serves as lipid chaperone for the proper folding of other membrane proteins [148-150].   
Research in lipid biology and apoptosis indicates that the lipid composition of the 
mitochondrial membrane changes before, during and after MOMP [100, 104, 110].  Given our 
findings, it is possible that Bcl-xL and other Bcl-2 family members can be modulated by the lipid 
composition in vivo.  However, our study is the first extensive characterization in the modulation 
of membrane interactions of Bcl-xL by lipids.  Other groups have partially characterized the 
effect of lipids on the membrane interactions of Bax and Bid, however, those studies focused in 
few lipids and did not directly address membrane binding and insertion [101, 106].  Thus, to 
better understand the mechanisms of membrane action of the Bcl-2 family proteins, future 
research should focus on characterizing the effect of membrane lipids on the membrane-
modulated interactions of multiple members of the Bcl-2 family.  
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